Peter Kowey

TitleVolunteer Faculty
InstitutionThomas Jefferson University
DepartmentFaculty Records
Address833 Chestnut Street
Philadelphia PA 19107
vCardDownload vCard

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Kutner TM, Kowey PR. The revenge of the P wave. J Cardiovasc Electrophysiol. 2024 Jun 28. PMID: 38940237.
      Citations:    
    2. Kowey PR, Olleik FM. Class IC Drugs in Cardiomyopathy: Keeping an Open Mind. JACC Clin Electrophysiol. 2024 May; 10(5):854-856. PMID: 38811068.
      Citations:    
    3. Piccini JP, Ahlsson A, Dorian P, Gillinov AM, Kowey PR, Mack MJ, Milano CA, Noiseux N, Perrault LP, Ryan W, Steinberg JS, Voisine P, Waldron NH, Gleason KJ, Titanji W, Leaback RD, O'Sullivan A, Ferguson WG, Benussi S. Efficacy and Safety of Botulinum Toxin Type A for the Prevention of Postoperative Atrial Fibrillation. JACC Clin Electrophysiol. 2024 May; 10(5):930-940. PMID: 38661602.
      Citations:    
    4. Ruskin JN, Camm AJ, Dufton C, Woite-Silva AC, Tuininga Y, Badings E, De Jong JSSG, Oosterhof T, Aksoy I, Kuijper AFM, Van Gelder IC, van Dijk V, Nuyens D, Schellings D, Lee MY, Kowey PR, Crijns HJGM, Maupas J, Belardinelli L. Orally Inhaled Flecainide for Conversion of Atrial Fibrillation to Sinus Rhythm: INSTANT Phase 2 Trial. JACC Clin Electrophysiol. 2024 Jun; 10(6):1021-1033. PMID: 38613545.
      Citations:    
    5. Kowey PR, Naccarelli GV. Antiarrhythmic Drug Therapy: Where Do We Go From Here? Circulation. 2024 Mar 12; 149(11):801-803. PMID: 38466788.
      Citations:    
    6. Reiffel JA, Kowey PR, Naccarelli GV. Should Patients with Subclinical Atrial Fibrillation Receive Anticoagulation? Am J Med. 2024 Jan 26. PMID: 38281654.
      Citations:    
    7. Camm AJ, Piccini JP, Alings M, Dorian P, Gosselin G, Guertin MC, Ip JE, Kowey PR, Mond?sert B, Prins FJ, Roux JF, Stambler BS, van Eck JWM, Al Windy N, Thermil N, Shardonofsky S, Bharucha DB, Roy D. A Multicenter, Phase 2, Randomized, Controlled Study of the Efficacy and Safety of Etripamil Nasal Spray for the Acute Reduction of Rapid Ventricular Rate in Patients with Symptomatic Atrial Fibrillation (ReVeRA-201). Circ Arrhythm Electrophysiol. 2023 Nov 11. PMID: 37950726.
      Citations:    
    8. Spears J, Liskov S, Camm AJ, Kowey PR. How Antiarrhythmic Drugs Are Being Used in Patients With Heart Failure: Results of a Global Survey of Cardiologists. Am J Cardiol. 2023 Sep 06; 206:60-62. PMID: 37683578.
      Citations:    
    9. Newman JA, Kowey PR. Predicting Post-Operative Atrial Fibrillation (POAF): The Proof Is in the Fluid. Trends Cardiovasc Med. 2023 Jul 25. PMID: 37499957.
      Citations:    
    10. Pundi K, Fan J, Kabadi S, Din N, Blomstr?m-Lundqvist C, John Camm A, Kowey P, Singh JP, Rashkin J, Wieloch M, Turakhia MP, Sandhu AT. Dronedarone Versus Sotalol in Antiarrhythmic Drug-Naive Veterans With Atrial Fibrillation. Circ Arrhythm Electrophysiol. 2023 Jul 24; e011893. PMID: 37485722.
      Citations:    
    11. Stambler BS, Camm AJ, Alings M, Dorian P, Heidbuchel H, Houtgraaf J, Kowey PR, Merino JL, Mond?sert B, Piccini JP, Pokorney SD, Sager PT, Verma A, Wharton JM, Bharucha DB, Plat F, Shardonofsky S, Chen M, Ip JE. Self-administered intranasal etripamil using a symptom-prompted, repeat-dose regimen for atrioventricular-nodal-dependent supraventricular tachycardia (RAPID): a multicentre, randomised trial. Lancet. 2023 Jul 08; 402(10396):118-128. PMID: 37331368.
      Citations:    
    12. Reiffel JA, Blomstr?m-Lundqvist C, Boriani G, Goette A, Kowey PR, Merino JL, Piccini JP, Saksena S, Camm AJ. Real-world utilization of the pill-in-the-pocket method for terminating episodes of atrial fibrillation: data from the multinational Antiarrhythmic Interventions for Managing Atrial Fibrillation (AIM-AF) survey. Europace. 2023 Jun 02; 25(6). PMID: 37354453.
      Citations:    
    13. Singh JP, Blomstr?m-Lundqvist C, Turakhia MP, Camm AJ, Fazeli MS, Kreidieh B, Crotty C, Kowey PR. Dronedarone versus sotalol in patients with atrial fibrillation: A systematic literature review and network meta-analysis. Clin Cardiol. 2023 Apr 06. PMID: 37025083.
      Citations:    
    14. Tack J, Derakhchan K, Gabriel A, Spalding W, Terreri B, Youssef A, Kreidieh B, Kowey PR, Boules M. A Review of the Cardiovascular Safety of Prucalopride in Patients with Chronic Idiopathic Constipation. Am J Gastroenterol. 2023 Mar 16. PMID: 36927957.
      Citations:    
    15. Hsu JC, Darden D, Du C, Marine JE, Nichols S, Marcus GM, Natale A, Noseworthy PA, Selzman KA, Varosy P, Masoudi F, Freeman J, Curtis J, Akar J, Kowey PR. Initial Findings From the National Cardiovascular Data Registry of Atrial Fibrillation Ablation Procedures. J Am Coll Cardiol. 2023 Mar 07; 81(9):867-878. PMID: 36858707.
      Citations:    
    16. Olshansky B, Bhatt DL, Miller M, Steg PG, Brinton EA, Jacobson TA, Ketchum SB, Doyle RT, Juliano RA, Jiao L, Kowey PR, Reiffel JA, Tardif JC, Ballantyne CM, Chung MK. Cardiovascular Benefits of Icosapent Ethyl in Patients With and Without Atrial Fibrillation in REDUCE-IT. J Am Heart Assoc. 2023 Feb 21; e026756. PMID: 36802845.
      Citations:    
    17. Reiffel JA, Robinson VM, Kowey PR. Perspective on Antiarrhythmic Drug Combinations. Am J Cardiol. 2023 Feb 11; 192:116-123. PMID: 36787682.
      Citations:    
    18. Spears J, Strony J, Kowey PR. Factor XI/XIa Inhibitors?Here We Go Again! Am J Med. 2023 Feb 02. PMID: 36739063.
      Citations:    
    19. Spears J, Kowey P. Amiodarone for the prevention of shocks and death in patients with implantable cardioverter-defibrillators: Hero or villain? Heart Rhythm. 2023 Jan 09. PMID: 36634902.
      Citations:    
    20. Garcia A, Lee J, Balasubramanian V, Gardner R, Gummidipundi SE, Hung G, Ferris T, Cheung L, Desai S, Granger CB, Hills MT, Kowey P, Nag D, Rumsfeld JS, Russo AM, Stein JW, Talati N, Tsay D, Mahaffey KW, Perez MV, Turakhia MP, Hedlin H, Desai M. The development of a mobile app-focused deduplication strategy for the Apple Heart Study that informs recommendations for future digital trials. Stat (Int Stat Inst). 2022 Dec; 11(1):e470. PMID: 36589778.
      Citations:    
    21. Omondi A, Sirinvaravong N, Spears J, Sauerwein S, Taoutel R, Liskov S, Gao C, Liu T, Kowey PR, Yan GX. Marked QTc Reduction Immediately Following Direct Current Cardioversion of Atrial Fibrillation: Clinical Implications and Mechanisms. JACC Clin Electrophysiol. 2022 Nov 16. PMID: 36752461.
      Citations:    
    22. Naccarelli GV, Kowey PR. Should we limit antiarrhythmic drug choice in patients with left ventricular hypertrophy? J Cardiovasc Electrophysiol. 2023 Feb; 34(2):453-454. PMID: 36335634.
      Citations:    
    23. Carlisle MA, Shrader P, Fudim M, Pieper KS, Blanco RG, Fonarow GC, Naccarelli GV, Gersh BJ, Reiffel JA, Kowey PR, Steinberg BA, Freeman JV, Ezekowitz MD, Singer DE, Allen LA, Chan PS, Pokorney SD, Peterson ED, Piccini JP. Residual stroke risk despite oral anticoagulation in patients with atrial fibrillation. Heart Rhythm O2. 2022 Dec; 3(6Part A):621-628. PMID: 36589908.
      Citations:    
    24. Liskov S, Belardinelli L, Kowey P. I'm Sorry, Ms Jones, But We Cannot Make You Feel Better Today. Circulation. 2022 Aug 30; 146(9):655-656. PMID: 36037267.
      Citations:    
    25. Handelsman Y, Bunch TJ, Rodbard HW, Steinberg BA, Thind M, Bigot G, Konigsberg L, Wieloch M, Kowey PR. Impact of dronedarone on patients with atrial fibrillation and diabetes: A sub-analysis of the ATHENA and EURIDIS/ADONIS studies. J Diabetes Complications. 2022 07; 36(7):108227. PMID: 35717354.
      Citations:    
    26. Garcia A, Balasubramanian V, Lee J, Gardner R, Gummidipundi S, Hung G, Ferris T, Cheung L, Granger C, Kowey P, Rumsfeld J, Russo A, Hills MT, Talati N, Nag D, Stein J, Tsay D, Desai S, Mahaffey K, Turakhia M, Perez M, Hedlin H, Desai M. Lessons learned in the Apple Heart Study and implications for the data management of future digital clinical trials. J Biopharm Stat. 2022 05 04; 32(3):496-510. PMID: 35695137.
      Citations:    
    27. Robinson VM, Di Diego JM, Bowes MT, Kowey PR, Antzelevitch C, Venetucci L. Increased susceptibility to ventricular arrhythmia at low-normal and moderately low levels of extracellular potassium in catecholaminergic polymorphic ventricular tachycardia. Heart Rhythm. 2022 08; 19(8):1389-1391. PMID: 35429650.
      Citations:    
    28. Camm AJ, Blomstr?m-Lundqvist C, Boriani G, Goette A, Kowey PR, Merino JL, Piccini JP, Saksena S, Reiffel JA. AIM-AF: A Physician Survey in the United States and Europe. J Am Heart Assoc. 2022 03 15; 11(6):e023838. PMID: 35243874.
      Citations:    
    29. Crijns HJGM, Elvan A, Al-Windy N, Tuininga YS, Badings E, Aksoy I, Van Gelder IC, Madhavapeddi P, Camm AJ, Kowey PR, Ruskin JN, Belardinelli L. Open-Label, Multicenter Study of Flecainide Acetate Oral Inhalation Solution for Acute Conversion of Recent-Onset, Symptomatic Atrial Fibrillation to Sinus Rhythm. Circ Arrhythm Electrophysiol. 2022 03; 15(3):e010204. PMID: 35196871.
      Citations:    
    30. Thind M, McKindley DS, Reiffel JA, Naccarelli GV, Stewart J, Kowey PR. Predictors of dronedarone plasma drug concentrations and effect on atrial fibrillation/atrial flutter recurrence: Analyses from the EURIDIS and ADONIS studies. Clin Cardiol. 2022 Jan; 45(1):119-128. PMID: 35032136.
      Citations:    
    31. Thind M, Zareba W, Atar D, Crijns HJGM, Zhu J, Pak HN, Reiffel J, Ludwigs U, Wieloch M, Stewart J, Kowey P. Efficacy and safety of dronedarone versus placebo in patients with atrial fibrillation stratified according to renal function: Post hoc analyses of the EURIDIS-ADONIS trials. Clin Cardiol. 2022 Jan; 45(1):101-109. PMID: 35019175.
      Citations:    
    32. Piccini JP, Ahlsson A, Dorian P, Gillinov MA, Kowey PR, Mack MJ, Milano CA, Perrault LP, Steinberg JS, Waldron NH, Adams LM, Bharucha DB, Brin MF, Ferguson WG, Benussi S. Design and Rationale of a Phase 2 Study of NeurOtoxin (Botulinum Toxin Type A) for the PreVention of Post-Operative Atrial Fibrillation - The NOVA Study. Am Heart J. 2022 03; 245:51-59. PMID: 34687654.
      Citations:    
    33. Perino AC, Gummidipundi SE, Lee J, Hedlin H, Garcia A, Ferris T, Balasubramanian V, Gardner RM, Cheung L, Hung G, Granger CB, Kowey P, Rumsfeld JS, Russo AM, True Hills M, Talati N, Nag D, Tsay D, Desai S, Desai M, Mahaffey KW, Turakhia MP, Perez MV. Arrhythmias Other Than Atrial Fibrillation in Those With an Irregular Pulse Detected With a Smartwatch: Findings From the Apple Heart Study. Circ Arrhythm Electrophysiol. 2021 10; 14(10):e010063. PMID: 34565178.
      Citations:    
    34. Burashnikov A, Barajas-Martinez H, Cox R, Demitrack MA, Fossler MJ, Kramer M, Kleiman RB, Kowey P, Antzelevitch C. Intracellular uptake of agents that block the hERG channel can confound the assessment of QT interval prolongation and arrhythmic risk. Heart Rhythm. 2021 12; 18(12):2177-2186. PMID: 34481984.
      Citations:    
    35. Albers GW, Bernstein R, Brachmann J, Camm AJ, Fromm P, Goto S, Granger CB, Hohnloser SH, Hylek E, Krieger D, Passman R, Pines JM, Kowey P. Reexamination of the Embolic Stroke of Undetermined Source Concept. Stroke. 2021 08; 52(8):2715-2722. PMID: 34192898.
      Citations:    
    36. Elkind MSV, Wachter R, Verma A, Kowey PR, Halperin JL, Gersh BJ, Ziegler PD, Pouliot E, Franco N, Reiffel JA. Use of the HAVOC Score to Identify Patients at Highest Risk of Developing Atrial Fibrillation. Cardiology. 2021; 146(5):633-640. PMID: 34157712.
      Citations:    
    37. Kowey PR. A most remarkable person: Dr Bernard Lown. Eur Heart J. 2021 05 21; 42(20):1938-1939. PMID: 33822928.
      Citations:    
    38. Kreidieh B, Thind M, Kowey PR. Cherry-picking atrial fibrillation ablation responders: Can antiarrhythmic drugs help? Heart Rhythm. 2021 09; 18(9):1480-1481. PMID: 34029732.
      Citations:    
    39. Jackson LR, Schrader P, Thomas L, Steinberg BA, Blanco R, Allen LA, Fonarow GC, Freeman JV, Gersh BJ, Kowey PR, Mahaffey KW, Naccarelli G, Reiffel J, Singer DE, Peterson ED, Piccini JP. Dosing of Direct Oral Anticoagulants in Patients with Moderate Chronic Kidney Disease in US Clinical Practice: Results from the Outcomes Registry for Better Informed Treatment of AF (ORBIT-AF II). Am J Cardiovasc Drugs. 2021 Sep; 21(5):553-561. PMID: 33786798.
      Citations:    
    40. Turakhia M, Sundaram V, Smith SN, Ding V, Michael Ho P, Kowey PR, Piccini JP, Foody J, Birmingham MC, Ianus J, Rajmane A, Mahaffey KW. Efficacy of a centralized, blended electronic, and human intervention to improve direct oral anticoagulant adherence: Smartphones to improve rivaroxaban ADHEREnce in atrial fibrillation (SmartADHERE) a randomized clinical trial. Am Heart J. 2021 07; 237:68-78. PMID: 33676886.
      Citations:    
    41. Reiffel JA, Verma A, Kowey PR, Halperin JL, Gersh BJ, Wachter R, Elkind MSV, Pouliot E, Ziegler PD. Relation of Antecedent Symptoms to the Likelihood of Detecting Subclinical Atrial Fibrillation With Inserted Cardiac Monitors. Am J Cardiol. 2021 04 15; 145:64-68. PMID: 33497655.
      Citations:    
    42. Robinson VM, Thind M, Kowey PR. Corroboration equals collaboration. Heart Rhythm. 2021 05; 18(5):682-683. PMID: 33497792.
      Citations:    
    43. Kowey PR, Robinson VM, Thind M. Medicine on Twitter: Boon or Bane? Circ Arrhythm Electrophysiol. 2021 01; 14(1):e009434. PMID: 33464944.
      Citations:    
    44. Ali-Ahmed F, Pieper K, North R, Allen LA, Chan PS, Ezekowitz MD, Fonarow GC, Freeman JV, Go AS, Gersh BJ, Kowey PR, Mahaffey KW, Naccarelli GV, Pokorney SD, Reiffel JA, Singer DE, Steinberg BA, Peterson ED, Piccini JP, O'Brien EC. Shared decision-making in atrial fibrillation: patient-reported involvement in treatment decisions. Eur Heart J Qual Care Clin Outcomes. 2020 10 01; 6(4):263-272. PMID: 32392287.
      Citations:    
    45. Thind M, Sullivan RM, Williams RN, Kowey PR. Bretylium, a Class III Antiarrhythmic, Returns to the Market. Am J Cardiol. 2020 10 15; 133:77-80. PMID: 32843146.
      Citations:    
    46. Madhavan M, Holmes DN, Piccini JP, Freeman JV, Fonarow GC, Hylek EM, Kowey PR, Mahaffey KW, Pieper K, Peterson ED, Chan PS, Allen LA, Singer DE, Naccarelli GV, Reiffel JA, Steinberg BA, Gersh BJ. Effect of Temporary Interruption of Warfarin Due to an Intervention on Downstream Time in Therapeutic Range in Patients With Atrial Fibrillation (from ORBIT AF). Am J Cardiol. 2020 10 01; 132:66-71. PMID: 32826041.
      Citations:    
    47. Geurink K, Holmes D, Ezekowitz MD, Pieper K, Fonarow G, Kowey PR, Reiffel JA, Singer DE, Freeman J, Gersh BJ, Mahaffey KW, Hylek EM, Naccarelli G, Piccini JP, Peterson ED, Pokorney SD. Patterns of oral anticoagulation use with cardioversion in clinical practice. Heart. 2021 04; 107(8):642-649. PMID: 32591363.
      Citations:    
    48. Sherwood MW, Piccini JP, Holmes DN, Pieper KS, Steinberg BA, Fonarow GC, Allen LA, Naccarelli GV, Kowey PR, Gersh BJ, Mahaffey KW, Singer DE, Ansell JE, Freeman JV, Chan PS, Reiffel JA, Blanco R, Peterson ED, Rao SV. Outcomes of Cardiac Catheterization in Patients With Atrial Fibrillation on Anticoagulation in Contemporary in Practice: An Analysis of the ORBIT II Registry. Circ Cardiovasc Interv. 2020 05; 13(5):e008274. PMID: 32408815.
      Citations:    
    49. Kowey PR, Robinson VM. The Relentless Pursuit of New Drugs to Treat Cardiac Arrhythmias. Circulation. 2020 05 12; 141(19):1507-1509. PMID: 32392105.
      Citations:    
    50. Jackson LR, Kim S, Blanco R, Thomas L, Ansell J, Fonarow GC, Gersh BJ, Go AS, Kowey PR, Mahaffey KW, Hylek EM, Peterson ED, Piccini JP. Discontinuation rates of warfarin versus direct acting oral anticoagulants in US clinical practice: Results from Outcomes Registry for Better Informed Treatment of Atrial Fibrillation II (ORBIT-AF II). Am Heart J. 2020 08; 226:85-93. PMID: 32526533.
      Citations:    
    51. Steinberg BA, Holmes DN, Pieper K, Allen LA, Chan PS, Ezekowitz MD, Freeman JV, Fonarow GC, Gersh BJ, Hylek EM, Kowey PR, Mahaffey KW, Naccarelli G, Reiffel J, Singer DE, Peterson ED, Piccini JP. Factors Associated With Large Improvements in Health-Related Quality of Life in Patients With Atrial Fibrillation: Results From ORBIT-AF. Circ Arrhythm Electrophysiol. 2020 05; 13(5):e007775. PMID: 32298144.
      Citations:    
    52. Thind M, Crijns HJ, Naccarelli GV, Reiffel JA, Corp Dit Genti V, Wieloch M, Koren A, Kowey PR. Dronedarone treatment following cardioversion in patients with atrial fibrillation/flutter: A post hoc analysis of the EURIDIS and ADONIS trials. J Cardiovasc Electrophysiol. 2020 05; 31(5):1022-1030. PMID: 32083368.
      Citations:    
    53. Thind M, Kowey PR. The Role of the Food and Drug Administration in Drug Development: On the Subject of Proarrhythmia Risk. J Innov Card Rhythm Manag. 2020 Jan; 11(1):3958-3967. PMID: 32368365.
      Citations:    
    54. Inohara T, Holmes DN, Pieper K, Blanco RG, Allen LA, Fonarow GC, Gersh BJ, Hylek EM, Ezekowitz MD, Kowey PR, Reiffel JA, Naccarelli GV, Chan PS, Mahaffey KW, Singer DE, Freeman JV, Steinberg BA, Peterson ED, Piccini JP. Decline in renal function and oral anticoagulation dose reduction among patients with atrial fibrillation. Heart. 2020 03; 106(5):358-364. PMID: 31911503.
      Citations:    
    55. Dalgaard F, North R, Pieper K, Fonarow GC, Kowey PR, Gersh BJ, Mahaffey KW, Pokorney S, Steinberg BA, Naccarrelli G, Allen LA, Reiffel JA, Ezekowitz M, Singer DE, Chan PS, Peterson ED, Piccini JP. Risk of major cardiovascular and neurologic events with obstructive sleep apnea among patients with atrial fibrillation. Am Heart J. 2020 05; 223:65-71. PMID: 32179257.
      Citations:    
    56. Reiffel JA, Verma A, Kowey PR, Halperin JL, Gersh BJ, Elkind MSV, Ziegler PD, Kaplon RE, Sherfesee L, Wachter R. Rhythm monitoring strategies in patients at high risk for atrial fibrillation and stroke: A comparative analysis from the REVEAL AF study. Am Heart J. 2020 01; 219:128-136. PMID: 31862084.
      Citations:    
    57. Vamos M, Calkins H, Kowey PR, Torp-Pedersen CT, Corp Dit Genti V, Wieloch M, Koren A, Hohnloser SH. Efficacy and safety of dronedarone in patients with a prior ablation for atrial fibrillation/flutter: Insights from the ATHENA study. Clin Cardiol. 2020 Mar; 43(3):291-297. PMID: 31872901.
      Citations:    
    58. Freeman JV, Shrader P, Pieper KS, Allen LA, Chan PS, Fonarow GC, Gersh BJ, Kowey PR, Mahaffey KW, Naccarelli G, Reiffel JA, Singer DE, Go AS, Hylek EM, Steinberg BA, Peterson ED, Piccini JP. Outcomes and Anticoagulation Use After Catheter Ablation for Atrial Fibrillation. Circ Arrhythm Electrophysiol. 2019 12; 12(12):e007612. PMID: 31830822.
      Citations:    
    59. Perez MV, Mahaffey KW, Hedlin H, Rumsfeld JS, Garcia A, Ferris T, Balasubramanian V, Russo AM, Rajmane A, Cheung L, Hung G, Lee J, Kowey P, Talati N, Nag D, Gummidipundi SE, Beatty A, Hills MT, Desai S, Granger CB, Desai M, Turakhia MP. Large-Scale Assessment of a Smartwatch to Identify Atrial Fibrillation. N Engl J Med. 2019 11 14; 381(20):1909-1917. PMID: 31722151.
      Citations:    
    60. Kowey PR, Robinson VM. The Evolution of the One-Armed Bandit. J Am Coll Cardiol. 2019 11 12; 74(19):2376-2378. PMID: 31699277.
      Citations:    
    61. Li Z, Mirams GR, Yoshinaga T, Ridder BJ, Han X, Chen JE, Stockbridge NL, Wisialowski TA, Damiano B, Severi S, Morissette P, Kowey PR, Holbrook M, Smith G, Rasmusson RL, Liu M, Song Z, Qu Z, Leishman DJ, Steidl-Nichols J, Rodriguez B, Bueno-Orovio A, Zhou X, Passini E, Edwards AG, Morotti S, Ni H, Grandi E, Clancy CE, Vandenberg J, Hill A, Nakamura M, Singer T, Polonchuk L, Greiter-Wilke A, Wang K, Nave S, Fullerton A, Sobie EA, Paci M, Musuamba Tshinanu F, Strauss DG. General Principles for the Validation of Proarrhythmia Risk Prediction Models: An Extension of the CiPA In Silico Strategy. Clin Pharmacol Ther. 2020 01; 107(1):102-111. PMID: 31709525.
      Citations:    
    62. Pokorney SD, Holmes DN, Shrader P, Thomas L, Fonarow GC, Mahaffey KW, Gersh BJ, Kowey PR, Naccarelli GV, Freeman JV, Singer DE, Washam JB, Peterson ED, Piccini JP, Reiffel JA. Patterns of amiodarone use and outcomes in clinical practice for atrial fibrillation. Am Heart J. 2020 02; 220:145-154. PMID: 31812756.
      Citations:    
    63. Pokorney SD, Holmes DN, Thomas L, Fonarow GC, Kowey PR, Reiffel JA, Singer DE, Freeman JV, Gersh BJ, Mahaffey KW, Hylek EM, Naccarelli GV, Ezekowitz MD, Piccini JP, Peterson ED. Association Between Warfarin Control Metrics and Atrial Fibrillation Outcomes in the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation. JAMA Cardiol. 2019 08 01; 4(8):756-764. PMID: 31268487.
      Citations:    
    64. Verma A, Wachter R, Kowey PR, Halperin JL, Gersh BJ, Elkind MSV, Kaplon RE, Ziegler PD, Sherfesee L, Reiffel JA. Changes in Management Following Detection of Previously Unknown Atrial Fibrillation by an Insertable Cardiac Monitor (from the REVEAL AF Study). Am J Cardiol. 2019 09 15; 124(6):864-870. PMID: 31303247.
      Citations:    
    65. Perino AC, Shrader P, Turakhia MP, Ansell JE, Gersh BJ, Fonarow GC, Go AS, Kaiser DW, Hylek EM, Kowey PR, Singer DE, Thomas L, Steinberg BA, Peterson ED, Piccini JP, Mahaffey KW. Comparison of Patient-Reported Care Satisfaction, Quality of Warfarin Therapy, and Outcomes of Atrial Fibrillation: Findings From the ORBIT - AF Registry. J Am Heart Assoc. 2019 05 07; 8(9):e011205. PMID: 31023126.
      Citations:    
    66. Back SH, Kowey PR. Strategies to Reduce Recurrent Shocks Due to Ventricular Arrhythmias in Patients with an Implanted Cardioverter-Defibrillator. Arrhythm Electrophysiol Rev. 2019 05; 8(2):99-104. PMID: 31114683.
      Citations:    
    67. Holmes DN, Piccini JP, Allen LA, Fonarow GC, Gersh BJ, Kowey PR, O'Brien EC, Reiffel JA, Naccarelli GV, Ezekowitz MD, Chan PS, Singer DE, Spertus JA, Peterson ED, Thomas L. Defining Clinically Important Difference in the Atrial Fibrillation Effect on Quality-of-Life Score. Circ Cardiovasc Qual Outcomes. 2019 05; 12(5):e005358. PMID: 31092022.
      Citations:    
    68. Khaji A, Hanley C, Kowey PR. Atrial Fibrillation Ablation Should Be First-Line Therapy in Heart Failure Patients: CON. Cardiol Clin. 2019 May; 37(2):197-206. PMID: 30926021.
      Citations:    
    69. Inohara T, Shrader P, Pieper K, Blanco RG, Allen LA, Fonarow GC, Gersh BJ, Go AS, Ezekowitz MD, Kowey PR, Reiffel JA, Naccarelli GV, Chan PS, Mahaffey KW, Singer DE, Freeman JV, Steinberg BA, Peterson ED, Piccini JP. Treatment of atrial fibrillation with concomitant coronary or peripheral artery disease: Results from the outcomes registry for better informed treatment of atrial fibrillation II. Am Heart J. 2019 07; 213:81-90. PMID: 31129441.
      Citations:    
    70. Packer DL, Mark DB, Robb RA, Monahan KH, Bahnson TD, Poole JE, Noseworthy PA, Rosenberg YD, Jeffries N, Mitchell LB, Flaker GC, Pokushalov E, Romanov A, Bunch TJ, Noelker G, Ardashev A, Revishvili A, Wilber DJ, Cappato R, Kuck KH, Hindricks G, Davies DW, Kowey PR, Naccarelli GV, Reiffel JA, Piccini JP, Silverstein AP, Al-Khalidi HR, Lee KL. Effect of Catheter Ablation vs Antiarrhythmic Drug Therapy on Mortality, Stroke, Bleeding, and Cardiac Arrest Among Patients With Atrial Fibrillation: The CABANA Randomized Clinical Trial. JAMA. 2019 04 02; 321(13):1261-1274. PMID: 30874766.
      Citations:    
    71. Vemulapalli S, Inohara T, Kim S, Thomas L, Piccini JP, Patel MR, Chang P, Fonarow GC, Ezekowitz MD, Hylek E, Go AS, Kowey PR, Mahaffey KW, Gersh BJ, Peterson ED. Blood Pressure Control and Cardiovascular Outcomes in Patients With Atrial Fibrillation (From the ORBIT-AF Registry). Am J Cardiol. 2019 05 15; 123(10):1628-1636. PMID: 30846214.
      Citations:    
    72. Ritchey ME, Harding A, Hunter S, Peterson C, Sager PT, Kowey PR, Nguyen L, Thomas S, Cainzos-Achirica M, Rothman KJ, Andrews EB, Anthony MS. Cardiovascular Safety During and After Use of Phentermine and Topiramate. J Clin Endocrinol Metab. 2019 02 01; 104(2):513-522. PMID: 30247575.
      Citations:    
    73. Madhavan M, Holmes DN, Piccini JP, Ansell JE, Fonarow GC, Hylek EM, Kowey PR, Mahaffey KW, Thomas L, Peterson ED, Chan P, Allen LA, Gersh BJ. Association of frailty and cognitive impairment with benefits of oral anticoagulation in patients with atrial fibrillation. Am Heart J. 2019 05; 211:77-89. PMID: 30901602.
      Citations:    
    74. Camm AJ, Dorian P, Hohnloser SH, Kowey PR, Tyl B, Ni Y, Vandzhura V, Maison-Blanche P, de Melis M, Sanders P. A randomized, double-blind, placebo-controlled trial assessing the efficacy of S66913 in patients with paroxysmal atrial fibrillation. Eur Heart J Cardiovasc Pharmacother. 2019 01 01; 5(1):21-28. PMID: 30052825.
      Citations:    
    75. Kowey PR, Ahmad S. Cardioversion of obese patients: What is the weight of evidence? J Cardiovasc Electrophysiol. 2019 02; 30(2):162-163. PMID: 30556226.
      Citations:    
    76. Jackson LR, Kim S, Shrader P, Blanco R, Thomas L, Ezekowitz MD, Ansell J, Fonarow GC, Gersh BJ, Go AS, Kowey PR, Mahaffey KW, Hylek EM, Peterson ED, Piccini JP. Early therapeutic persistence on dabigatran versus warfarin therapy in patients with atrial fibrillation: results from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF) registry. J Thromb Thrombolysis. 2018 Nov; 46(4):435-439. PMID: 30051164.
      Citations:    
    77. Chia KKM, Kanagaratnam L, Hellestrand K, Kowey P, Whalley D. Pharmacological Therapy for Ventricular Arrhythmias: A State-of-the Art Review. Heart Lung Circ. 2019 Jan; 28(1):49-56. PMID: 30392983.
      Citations:    
    78. Inohara T, Kim S, Pieper K, Blanco RG, Allen LA, Fonarow GC, Gersh BJ, Ezekowitz MD, Kowey PR, Reiffel JA, Naccarelli GV, Chan PS, Mahaffey KW, Singer DE, Freeman JV, Steinberg BA, Peterson ED, Piccini JP. B-type natriuretic peptide, disease progression and clinical outcomes in atrial fibrillation. Heart. 2019 03; 105(5):370-377. PMID: 30228248.
      Citations:    
    79. Washam JB, Holmes DN, Thomas LE, Pokorney SD, Hylek EM, Fonarow GC, Mahaffey KW, Gersh BJ, Kowey PR, Ansell JE, Go AS, Reiffel JA, Freeman JV, Singer DE, Naccarelli G, Blanco R, Peterson ED, Piccini JP. Pharmacotherapy for Atrial Fibrillation in Patients With Chronic Kidney Disease: Insights From ORBIT-AF. J Am Heart Assoc. 2018 09 18; 7(18):e008928. PMID: 30371218.
      Citations:    
    80. Turakhia MP, Desai M, Hedlin H, Rajmane A, Talati N, Ferris T, Desai S, Nag D, Patel M, Kowey P, Rumsfeld JS, Russo AM, Hills MT, Granger CB, Mahaffey KW, Perez MV. Rationale and design of a large-scale, app-based study to identify cardiac arrhythmias using a smartwatch: The Apple Heart Study. Am Heart J. 2019 01; 207:66-75. PMID: 30392584.
      Citations:    
    81. O'Brien EC, Holmes DN, Thomas LE, Fonarow GC, Allen LA, Gersh BJ, Kowey PR, Singer DE, Ezekowitz MD, Naccarelli GV, Ansell JE, Chan PS, Mahaffey KW, Go AS, Freeman JV, Reiffel JA, Peterson ED, Piccini JP, Hylek EM. Prognostic Significance of Nuisance Bleeding in Anticoagulated Patients With Atrial Fibrillation. Circulation. 2018 08 28; 138(9):889-897. PMID: 29678813.
      Citations:    
    82. Jackson LR, Kim S, Fonarow GC, Freeman JV, Gersh BJ, Go AS, Hylek EM, Kowey PR, Mahaffey KW, Singer D, Thomas L, Blanco R, Peterson ED, Piccini JP. Stroke Risk and Treatment in Patients with Atrial Fibrillation and Low CHA2DS2-VASc Scores: Findings From the ORBIT-AF I and II Registries. J Am Heart Assoc. 2018 08 21; 7(16):e008764. PMID: 30369317.
      Citations:    
    83. Packer M, Kowey PR. Building Castles in the Sky: Catheter Ablation in Patients With Atrial Fibrillation and Chronic Heart Failure. Circulation. 2018 08 21; 138(8):751-753. PMID: 29848750.
      Citations:    
    84. Thind M, Holmes DN, Badri M, Pieper KS, Singh A, Blanco RG, Steinberg BA, Fonarow GC, Gersh BJ, Mahaffey KW, Peterson ED, Reiffel JA, Piccini JP, Kowey PR. Embolic and Other Adverse Outcomes in Symptomatic Versus Asymptomatic Patients With Atrial Fibrillation (from the ORBIT-AF Registry). Am J Cardiol. 2018 11 15; 122(10):1677-1683. PMID: 30227964.
      Citations:    
    85. O'Brien EC, Holmes DN, Thomas L, Singer DE, Fonarow GC, Mahaffey KW, Kowey PR, Hylek EM, Pokorney SD, Ansell JE, Pencina MJ, Peterson ED, Piccini JP. Incremental prognostic value of renal function for stroke prediction in atrial fibrillation. Int J Cardiol. 2019 Jan 01; 274:152-157. PMID: 30144994.
      Citations:    
    86. O'Brien EC, Holmes DN, Thomas L, Fonarow GC, Kowey PR, Ansell JE, Mahaffey KW, Gersh BJ, Peterson ED, Piccini JP, Hylek EM. Therapeutic Strategies Following Major, Clinically Relevant Nonmajor,?and Nuisance Bleeding in Atrial Fibrillation: Findings From?ORBIT-AF. J Am Heart Assoc. 2018 06 09; 7(12). PMID: 29886422.
      Citations:    
    87. Aziz PF, Berger S, Kowey P, Krucoff M, Lopez-Anderson M, Michelson E, Molossi S, Morrow V, Rodriguez I, Saarel TE, Strnadova C, Vetter V, Wright TJ, Idriss SF. The Second Annual Think Tank on Prevention of Sudden Cardiac Death in the Young: Developing a rational, reliable, and sustainable national health care resource. A report from the Cardiac Safety Research Consortium. Am Heart J. 2018 08; 202:104-108. PMID: 29920452.
      Citations:    
    88. Turner JR, Rodriguez I, Mantovani E, Gintant G, Kowey PR, Klotzbaugh RJ, Prasad K, Sager PT, Stockbridge N, Strnadova C. Drug-induced Proarrhythmia and Torsade de Pointes: A Primer for Students and Practitioners of Medicine and Pharmacy. J Clin Pharmacol. 2018 Aug; 58(8):997-1012. PMID: 29672845.
      Citations:    
    89. Kowey PR. Stroke Prevention in Patients with Atrial Fibrillation. J Innov Card Rhythm Manag. 2018 Apr; 9(4):3091-3092. PMID: 32494487.
      Citations:    
    90. Fudim M, Liu PR, Shrader P, Blanco RG, Allen LA, Fonarow GC, Gersh BJ, Kowey PR, Mahaffey KW, Hylek E, Go AS, Thomas L, Peterson ED, Piccini JP. Mineralocorticoid Receptor Antagonism in Patients With Atrial Fibrillation: Findings From the ORBIT-AF (Outcomes Registry for Better Informed Treatment of Atrial Fibrillation) Registry. J Am Heart Assoc. 2018 04 13; 7(8). PMID: 29654203.
      Citations:    
    91. Dudzinsk JE, Gnall E, Kowey PR. A Review of percutaneous mechanical support devices and strategies. Rev Cardiovasc Med. 2018 Mar 30; 19(1):21-26. PMID: 31032599.
      Citations:    
    92. White WB, Kowey P, Diva U, Sostek M, Tummala R. Cardiovascular Safety of the Selective ?-Opioid Receptor Antagonist Naloxegol: A Novel Therapy for Opioid-Induced Constipation. J Cardiovasc Pharmacol Ther. 2018 07; 23(4):309-317. PMID: 29504415.
      Citations:    
    93. Anouti K, Kowey PR. Assessing intracardiac thrombus prior to cardioversion: A story yet to be told. J Cardiovasc Electrophysiol. 2018 04; 29(4):548-550. PMID: 29437262.
      Citations:    
    94. Steinberg BA, Shrader P, Pieper K, Thomas L, Allen LA, Ansell J, Chan PS, Ezekowitz MD, Fonarow GC, Freeman JV, Gersh BJ, Kowey PR, Mahaffey KW, Naccarelli GV, Reiffel JA, Singer DE, Peterson ED, Piccini JP. Frequency and Outcomes of Reduced Dose Non-Vitamin K Antagonist Anticoagulants: Results From ORBIT-AF II (The Outcomes Registry for Better Informed Treatment of Atrial Fibrillation II). J Am Heart Assoc. 2018 02 16; 7(4). PMID: 29453305.
      Citations:    
    95. Inohara T, Shrader P, Pieper K, Blanco RG, Thomas L, Singer DE, Freeman JV, Allen LA, Fonarow GC, Gersh B, Ezekowitz MD, Kowey PR, Reiffel JA, Naccarelli GV, Chan PS, Steinberg BA, Peterson ED, Piccini JP. Association of of Atrial Fibrillation Clinical Phenotypes With Treatment Patterns and Outcomes: A Multicenter Registry Study. JAMA Cardiol. 2018 01 01; 3(1):54-63. PMID: 29128866.
      Citations:    
    96. Thomas KL, Jackson LR, Shrader P, Ansell J, Fonarow GC, Gersh B, Kowey PR, Mahaffey KW, Singer DE, Thomas L, Piccini JP, Peterson ED. Prevalence, Characteristics, and Outcomes of Valvular Heart Disease in Patients With Atrial Fibrillation: Insights From the ORBIT-AF (Outcomes Registry for Better Informed Treatment for Atrial Fibrillation). J Am Heart Assoc. 2017 12 22; 6(12). PMID: 29273635.
      Citations:    
    97. Barnett AS, Kim S, Fonarow GC, Thomas LE, Reiffel JA, Allen LA, Freeman JV, Naccarelli G, Mahaffey KW, Go AS, Kowey PR, Ansell JE, Gersh BJ, Hylek EM, Peterson ED, Piccini JP. Treatment of Atrial Fibrillation and Concordance With the American Heart Association/American College of Cardiology/Heart Rhythm Society Guidelines: Findings From ORBIT-AF (Outcomes Registry for Better Informed Treatment of Atrial Fibrillation). Circ Arrhythm Electrophysiol. 2017 Nov; 10(11). PMID: 29141842.
      Citations:    
    98. Khaji A, Kowey PR. The tyranny of numbers, large and small. J Cardiovasc Electrophysiol. 2017 12; 28(12):1443-1444. PMID: 29024070.
      Citations:    
    99. Reiffel JA, Verma A, Kowey PR, Halperin JL, Gersh BJ, Wachter R, Pouliot E, Ziegler PD. Incidence of Previously Undiagnosed Atrial Fibrillation Using Insertable Cardiac Monitors in a High-Risk Population: The REVEAL AF Study. JAMA Cardiol. 2017 10 01; 2(10):1120-1127. PMID: 28842973.
      Citations:    
    100. Echouffo-Tcheugui JB, Shrader P, Thomas L, Gersh BJ, Kowey PR, Mahaffey KW, Singer DE, Hylek EM, Go AS, Peterson ED, Piccini JP, Fonarow GC. Care Patterns and Outcomes in Atrial?Fibrillation Patients With and Without Diabetes: ORBIT-AF Registry. J Am Coll Cardiol. 2017 Sep 12; 70(11):1325-1335. PMID: 28882229.
      Citations:    
    101. Kanagaratnam L, Kowey P, Whalley D. Pharmacological Therapy for Rate and Rhythm Control for Atrial Fibrillation in 2017. Heart Lung Circ. 2017 Sep; 26(9):926-933. PMID: 28778376.
      Citations:    
    102. Steinberg BA, Gao H, Shrader P, Pieper K, Thomas L, Camm AJ, Ezekowitz MD, Fonarow GC, Gersh BJ, Goldhaber S, Haas S, Hacke W, Kowey PR, Ansell J, Mahaffey KW, Naccarelli G, Reiffel JA, Turpie A, Verheugt F, Piccini JP, Kakkar A, Peterson ED, Fox KAA. International trends in clinical characteristics and oral anticoagulation treatment for patients with atrial fibrillation: Results from the GARFIELD-AF, ORBIT-AF I, and ORBIT-AF II registries. Am Heart J. 2017 Dec; 194:132-140. PMID: 29223431.
      Citations:    
    103. Kaufman BG, Kim S, Pieper K, Allen LA, Gersh BJ, Naccarelli GV, Ezekowitz MD, Fonarow GC, Mahaffey KW, Singer DE, Chan PS, Freeman JV, Ansell J, Kowey PR, Rieffel JA, Piccini J, Peterson E, O'Brien EC. Disease understanding in patients newly diagnosed with atrial fibrillation. Heart. 2018 03; 104(6):494-501. PMID: 28790169.
      Citations:    
    104. Melloni C, Shrader P, Carver J, Piccini JP, Thomas L, Fonarow GC, Ansell J, Gersh B, Go AS, Hylek E, Herling IM, Mahaffey KW, Yu AF, Peterson ED, Kowey PR. Management and outcomes of patients with atrial fibrillation and a history of cancer: the ORBIT-AF registry. Eur Heart J Qual Care Clin Outcomes. 2017 07 01; 3(3):192-197. PMID: 28838088.
      Citations:    
    105. Black-Maier E, Kim S, Steinberg BA, Fonarow GC, Freeman JV, Kowey PR, Ansell J, Gersh BJ, Mahaffey KW, Naccarelli G, Hylek EM, Go AS, Peterson ED, Piccini JP. Oral anticoagulation management in patients with atrial fibrillation undergoing cardiac implantable electronic device implantation. Clin Cardiol. 2017 Sep; 40(9):746-751. PMID: 28543401.
      Citations:    
    106. Freedman B, Camm J, Calkins H, Healey JS, Rosenqvist M, Wang J, Albert CM, Anderson CS, Antoniou S, Benjamin EJ, Boriani G, Brachmann J, Brandes A, Chao TF, Conen D, Engdahl J, Fauchier L, Fitzmaurice DA, Friberg L, Gersh BJ, Gladstone DJ, Glotzer TV, Gwynne K, Hankey GJ, Harbison J, Hillis GS, Hills MT, Kamel H, Kirchhof P, Kowey PR, Krieger D, Lee VWY, Levin L?, Lip GYH, Lobban T, Lowres N, Mairesse GH, Martinez C, Neubeck L, Orchard J, Piccini JP, Poppe K, Potpara TS, Puererfellner H, Rienstra M, Sandhu RK, Schnabel RB, Siu CW, Steinhubl S, Svendsen JH, Svennberg E, Themistoclakis S, Tieleman RG, Turakhia MP, Tveit A, Uittenbogaart SB, Van Gelder IC, Verma A, Wachter R, Yan BP. Screening for Atrial Fibrillation: A Report of the AF-SCREEN International Collaboration. Circulation. 2017 05 09; 135(19):1851-1867. PMID: 28483832.
      Citations:    
    107. Steinberg BA, Shrader P, Thomas L, Ansell J, Fonarow GC, Gersh BJ, Hylek E, Kowey PR, Mahaffey KW, O'Brien EC, Singer DE, Peterson ED, Piccini JP. Factors associated with non-vitamin K antagonist oral anticoagulants for stroke prevention in patients with new-onset atrial fibrillation: Results from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation II (ORBIT-AF II). Am Heart J. 2017 Jul; 189:40-47. PMID: 28625380.
      Citations:    
    108. Steinberg BA, Simon DN, Thomas L, Ansell J, Fonarow GC, Gersh BJ, Kowey PR, Mahaffey KW, Peterson ED, Piccini JP. Management of Major Bleeding in Patients With Atrial Fibrillation Treated With Non-Vitamin K Antagonist Oral Anticoagulants Compared With Warfarin in Clinical Practice (from Phase II of the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation [ORBIT-AF II]). Am J Cardiol. 2017 05 15; 119(10):1590-1595. PMID: 28363354.
      Citations:    
    109. Wise RA, Kowey PR, Austen G, Mueller A, Metzdorf N, Fowler A, McGarvey LP. Discordance in investigator-reported and adjudicated sudden death in TIOSPIR. ERJ Open Res. 2017 Jan; 3(1). PMID: 28344980.
      Citations:    
    110. Yu H, Zhang L, Liu J, Liu Y, Kowey PR, Zhang Y, Chen Y, Wei Y, Gao L, Li H, Du J, Xia Y. Acquired long QT syndrome in hospitalized patients. Heart Rhythm. 2017 07; 14(7):974-978. PMID: 28323171.
      Citations:    
    111. Cherian TS, Shrader P, Fonarow GC, Allen LA, Piccini JP, Peterson ED, Thomas L, Kowey PR, Gersh BJ, Mahaffey KW. Effect of Atrial Fibrillation on Mortality, Stroke Risk, and Quality-of-Life Scores in Patients With Heart Failure (from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation [ORBIT-AF]). Am J Cardiol. 2017 06 01; 119(11):1763-1769. PMID: 28416199.
      Citations:    
    112. Hess PL, Healey JS, Granger CB, Connolly SJ, Ziegler PD, Alexander JH, Kowey PR, Ruff CT, Flaker G, Halperin JL, Hart RG, Lopes RD. The Role of Cardiovascular Implantable Electronic Devices in the Detection and Treatment of Subclinical Atrial Fibrillation: A Review. JAMA Cardiol. 2017 03 01; 2(3):324-331. PMID: 28097334.
      Citations:    
    113. Conti S, Reiffel JA, Gersh BJ, Kowey PR, Wachter R, Halperin JL, Kaplon RE, Pouliot E, Verma A. Baseline Demographics, Safety, and Patient Acceptance of an Insertable Cardiac Monitor for Atrial Fibrillation Screening: The REVEAL-AF Study. J Atr Fibrillation. 2017 Feb-Mar; 9(5):1551. PMID: 29250279.
      Citations:    
    114. Zakeri R, Van Wagoner DR, Calkins H, Wong T, Ross HM, Heist EK, Meyer TE, Kowey PR, Mentz RJ, Cleland JG, Pitt B, Zannad F, Linde C. The burden of proof: The current state of atrial fibrillation prevention and treatment trials. Heart Rhythm. 2017 05; 14(5):763-782. PMID: 28161513.
      Citations:    
    115. Piccini JP, Clark RL, Kowey PR, Mittal S, Dunnmon P, Stockbridge N, Reiffel JA, Turakhia MP, Ziegler PD, Kleiman RB, Ismat F, Sager P. Long-term electrocardiographic safety monitoring in clinical drug development: A report from the Cardiac Safety Research Consortium. Am Heart J. 2017 May; 187:156-169. PMID: 28454799.
      Citations:    
    116. Pandey A, Kim S, Moore C, Thomas L, Gersh B, Allen LA, Kowey PR, Mahaffey KW, Hylek E, Peterson ED, Piccini JP, Fonarow GC. Predictors and Prognostic Implications of?Incident Heart Failure in Patients With?Prevalent Atrial Fibrillation. JACC Heart Fail. 2017 01; 5(1):44-52. PMID: 28034376.
      Citations:    
    117. Steinberg BA, Shrader P, Thomas L, Ansell J, Fonarow GC, Gersh BJ, Kowey PR, Mahaffey KW, Naccarelli G, Reiffel J, Singer DE, Peterson ED, Piccini JP. Off-Label Dosing of Non-Vitamin K Antagonist Oral Anticoagulants and Adverse Outcomes: The ORBIT-AF II Registry. J Am Coll Cardiol. 2016 Dec 20; 68(24):2597-2604. PMID: 27978942.
      Citations:    
    118. Hanley CM, Kowey PR. Back to the basics. Heart Rhythm. 2017 03; 14(3):455-456. PMID: 27915057.
      Citations:    
    119. Hess PL, Kim S, Fonarow GC, Thomas L, Singer DE, Freeman JV, Gersh BJ, Ansell J, Kowey PR, Mahaffey KW, Chan PS, Steinberg BA, Peterson ED, Piccini JP. Absence of Oral Anticoagulation and Subsequent Outcomes Among Outpatients with Atrial Fibrillation. Am J Med. 2017 Apr; 130(4):449-456. PMID: 27888051.
      Citations:    
    120. Robinson VM, Bharucha DB, Mahaffey KW, Dorian P, Kowey PR. Results of a curtailed randomized controlled trial, evaluating the efficacy and safety of azimilide in patients with implantable cardioverter-defibrillators: The SHIELD-2 trial. Am Heart J. 2017 Mar; 185:43-51. PMID: 28267474.
      Citations:    
    121. Pokorney SD, Kim S, Thomas L, Fonarow GC, Kowey PR, Gersh BJ, Mahaffey KW, Peterson ED, Piccini JP. Cardioversion and subsequent quality of life and natural history of atrial fibrillation. Am Heart J. 2017 Mar; 185:59-66. PMID: 28267476.
      Citations:    
    122. Pokorney SD, Shrader P, Thomas L, Fonarow GC, Kowey PR, Singer DE, Ansell J, Gersh BJ, Mahaffey KW, Hylek EM, Go AS, Piccini JP, Peterson ED. Influence of Kidney Function Estimation Methods on Eligibility for Edoxaban Population Impact of the US Food and Drug Administration's Approach for Its Product Labeling. Circulation. 2016 10 11; 134(15):1122-1124. PMID: 27753615.
      Citations:    
    123. Darrat YH, Shah J, Elayi CS, Morales GX, Naditch-Br?l? L, Brette S, Taniou C, Kowey PR, Schwartz PJ. Regional Lack of Consistency in the Management of Atrial Fibrillation (from the RECORD-AF Trial). Am J Cardiol. 2017 Jan 01; 119(1):47-51. PMID: 27816112.
      Citations:    
    124. Ackerman MJ, Priori SG, Dubin AM, Kowey P, Linker NJ, Slotwiner D, Triedman J, Van Hare GF, Gold MR. Beta-blocker therapy for long QT syndrome and catecholaminergic polymorphic ventricular tachycardia: Are all beta-blockers equivalent? Heart Rhythm. 2017 01; 14(1):e41-e44. PMID: 27659101.
      Citations:    
    125. Kowey PR, Shah AM. Glass Half Empty? JACC Clin Electrophysiol. 2016 12; 2(7):782-783. PMID: 29759760.
      Citations:    
    126. Trikha R, Kowey PR. Practical Considerations for the Nonvitamin K Antagonist Oral Anticoagulants. Cardiology. 2017; 136(2):115-124. PMID: 27595409.
      Citations:    
    127. Steinberg BA, Shrader P, Kim S, Thomas L, Fonarow GC, Ansell J, Kowey PR, Singer DE, Gersh BJ, Mahaffey KW, Peterson ED, Piccini JP. How well does physician risk assessment predict stroke and bleeding in atrial fibrillation? Results from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF). Am Heart J. 2016 Nov; 181:145-152. PMID: 27823686.
      Citations:    
    128. Randolph TC, Simon DN, Thomas L, Allen LA, Fonarow GC, Gersh BJ, Kowey PR, Reiffel JA, Naccarelli GV, Chan PS, Spertus JA, Peterson ED, Piccini JP. Patient factors associated with quality of life in atrial fibrillation. Am Heart J. 2016 Dec; 182:135-143. PMID: 27914493.
      Citations:    
    129. Khaji A, Kowey PR. Update on atrial fibrillation. Trends Cardiovasc Med. 2017 01; 27(1):14-25. PMID: 27520496.
      Citations:    
    130. Hanley CM, Kowey PR. Darned If You Do?Darned If You Don't. J Cardiovasc Electrophysiol. 2016 07; 27(7):811-2. PMID: 27108489.
      Citations:    
    131. Piccini JP, Simon DN, Steinberg BA, Thomas L, Allen LA, Fonarow GC, Gersh B, Hylek E, Kowey PR, Reiffel JA, Naccarelli GV, Chan PS, Spertus JA, Peterson ED. Differences in Clinical and Functional Outcomes of Atrial Fibrillation in Women and Men: Two-Year Results From the ORBIT-AF Registry. JAMA Cardiol. 2016 06 01; 1(3):282-91. PMID: 27438106.
      Citations:    
    132. O'Brien EC, Kim S, Thomas L, Fonarow GC, Kowey PR, Mahaffey KW, Gersh BJ, Piccini JP, Peterson ED. Clinical Characteristics, Oral Anticoagulation Patterns, and Outcomes of Medicaid Patients With Atrial Fibrillation: Insights From the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF I) Registry. J Am Heart Assoc. 2016 05 04; 5(5). PMID: 27146448.
      Citations:    
    133. Turner JR, Kowey PR, Rodriguez I, Cabell CH, Gintant G, Green CL, Kunz BL, Mortara J, Sager PT, Stockbridge N, Wright TJ, Finkle J, Krucoff MW. The Cardiac Safety Research Consortium enters its second decade: An invitation to participate. Am Heart J. 2016 07; 177:96-101. PMID: 27297854.
      Citations:    
    134. Piccini JP, Pritchett EL, Davison BA, Cotter G, Wiener LE, Koch G, Feld G, Waldo A, van Gelder IC, Camm AJ, Kowey PR, Iwashita J, Dittrich HC. Randomized, double-blind, placebo-controlled study to evaluate the safety and efficacy of a single oral dose of vanoxerine for the conversion of subjects with recent onset atrial fibrillation or flutter to normal sinus rhythm: RESTORE SR. Heart Rhythm. 2016 09; 13(9):1777-83. PMID: 27108936.
      Citations:    
    135. Sardar MR, Saeed W, Kowey PR. Antiarrhythmic Drug Therapy for Atrial Fibrillation. Heart Fail Clin. 2016 Apr; 12(2):205-21. PMID: 26968666.
      Citations:    
    136. Albers GW, Bernstein RA, Brachmann J, Camm J, Easton JD, Fromm P, Goto S, Granger CB, Hohnloser SH, Hylek E, Jaffer AK, Krieger DW, Passman R, Pines JM, Reed SD, Rothwell PM, Kowey PR. Heart Rhythm Monitoring Strategies for Cryptogenic Stroke: 2015?Diagnostics and Monitoring Stroke Focus Group Report. J Am Heart Assoc. 2016 Mar 15; 5(3):e002944. PMID: 27068633.
      Citations:    
    137. Patton KK, Ellinor PT, Ezekowitz M, Kowey P, Lubitz SA, Perez M, Piccini J, Turakhia M, Wang P, Viskin S. Electrocardiographic Early Repolarization: A Scientific Statement From the American Heart Association. Circulation. 2016 Apr 12; 133(15):1520-9. PMID: 27067089.
      Citations:    
    138. Hanley CM, Robinson VM, Kowey PR. Status of Antiarrhythmic Drug Development for Atrial Fibrillation: New Drugs and New Molecular Mechanisms. Circ Arrhythm Electrophysiol. 2016 Mar; 9(3):e002479. PMID: 26936819.
      Citations:    
    139. Gundlund A, Fosb?l EL, Kim S, Fonarow GC, Gersh BJ, Kowey PR, Hylek E, Mahaffey KW, Thomas L, Piccini JP, Peterson ED. Family history of atrial fibrillation is associated with earlier-onset and more symptomatic atrial fibrillation: Results from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF) registry. Am Heart J. 2016 May; 175:28-35. PMID: 27179721.
      Citations:    
    140. Lopes RD, Rao M, Simon DN, Thomas L, Ansell J, Fonarow GC, Gersh BJ, Go AS, Hylek EM, Kowey P, Piccini JP, Singer DE, Chang P, Peterson ED, Mahaffey KW. Triple vs Dual Antithrombotic Therapy in Patients with Atrial Fibrillation and Coronary Artery Disease. Am J Med. 2016 06; 129(6):592-599.e1. PMID: 26797080.
      Citations:    
    141. Darpo B, Bjornsson TD, Brathwaite WA, Crincoli CM, Eapen AK, Fisher GL, Kowey PR, Miller MP, Nikiforov AI, Rihner MO, Zhou M. Detection of ECG effects of (2R,4R)-monatin, a sweet flavored isomer of a component first identified in the root bark of the Sclerochitin ilicifolius plant. Food Chem Toxicol. 2016 May; 91:217-24. PMID: 26747976.
      Citations:    
    142. Jackson LR, Kim SH, Piccini JP, Gersh BJ, Naccarelli GV, Reiffel JA, Freeman J, Thomas L, Chang P, Fonarow GC, Go AS, Mahaffey KW, Peterson ED, Kowey PR. Sinus Node Dysfunction Is Associated With Higher Symptom Burden and Increased Comorbid Illness: Results From the ORBIT-AF Registry. Clin Cardiol. 2016 Feb; 39(2):119-25. PMID: 26720750.
      Citations:    
    143. Golwala H, Jackson LR, Simon DN, Piccini JP, Gersh B, Go AS, Hylek EM, Kowey PR, Mahaffey KW, Thomas L, Fonarow GC, Peterson ED, Thomas KL. Racial/ethnic differences in atrial fibrillation symptoms, treatment patterns, and outcomes: Insights from Outcomes Registry for Better Informed Treatment for Atrial Fibrillation Registry. Am Heart J. 2016 Apr; 174:29-36. PMID: 26995367.
      Citations:    
    144. Pandey A, Gersh BJ, McGuire DK, Shrader P, Thomas L, Kowey PR, Mahaffey KW, Hylek E, Sun S, Burton P, Piccini J, Peterson E, Fonarow GC. Association of Body Mass Index With?Care?and Outcomes in Patients With?Atrial?Fibrillation: Results From the ORBIT-AF Registry. JACC Clin Electrophysiol. 2016 Jun; 2(3):355-363. PMID: 29766895.
      Citations:    
    145. Noheria A, Shrader P, Piccini JP, Fonarow GC, Kowey PR, Mahaffey KW, Naccarelli G, Noseworthy PA, Reiffel JA, Steinberg BA, Thomas LE, Peterson ED, Gersh BJ. Rhythm Control Versus Rate Control and?Clinical Outcomes in Patients With?Atrial Fibrillation: Results From the ORBIT-AF Registry. JACC Clin Electrophysiol. 2016 Apr; 2(2):221-229. PMID: 29766874.
      Citations:    
    146. Robinson VM, Kowey PR. Smoothing the Bumpy Road to Antiarrhythmic Drug Development. Circulation. 2015 Dec 08; 132(23):2195-7. PMID: 26499961.
      Citations:    
    147. O'Brien EC, Simon DN, Thomas LE, Hylek EM, Gersh BJ, Ansell JE, Kowey PR, Mahaffey KW, Chang P, Fonarow GC, Pencina MJ, Piccini JP, Peterson ED. The ORBIT bleeding score: a simple bedside score to assess bleeding risk in atrial fibrillation. Eur Heart J. 2015 Dec 07; 36(46):3258-64. PMID: 26424865.
      Citations:    
    148. Steinberg BA, Kim S, Thomas L, Fonarow GC, Gersh BJ, Holmqvist F, Hylek E, Kowey PR, Mahaffey KW, Naccarelli G, Reiffel JA, Chang P, Peterson ED, Piccini JP. Increased Heart Rate Is Associated With Higher Mortality in Patients With Atrial Fibrillation (AF): Results From the Outcomes Registry for Better Informed Treatment of AF (ORBIT-AF). J Am Heart Assoc. 2015 Sep 14; 4(9):e002031. PMID: 26370445.
      Citations:    
    149. Kowey PR, Robinson VM. Observing the Obvious. J Am Coll Cardiol. 2015 Sep 01; 66(9):1008-10. PMID: 26314527.
      Citations:    
    150. Reiffel JA, Camm AJ, Belardinelli L, Zeng D, Karwatowska-Prokopczuk E, Olmsted A, Zareba W, Rosero S, Kowey P. The HARMONY Trial: Combined Ranolazine and Dronedarone in the Management of Paroxysmal Atrial Fibrillation: Mechanistic and Therapeutic Synergism. Circ Arrhythm Electrophysiol. 2015 Oct; 8(5):1048-56. PMID: 26226999.
      Citations:    
    151. Allen LA, Fonarow GC, Simon DN, Thomas LE, Marzec LN, Pokorney SD, Gersh BJ, Go AS, Hylek EM, Kowey PR, Mahaffey KW, Chang P, Peterson ED, Piccini JP. Digoxin Use and Subsequent Outcomes Among Patients in a Contemporary Atrial Fibrillation Cohort. J Am Coll Cardiol. 2015 Jun 30; 65(25):2691-8. PMID: 26112191.
      Citations:    
    152. Badri M, Patel A, Patel C, Liu G, Goldstein M, Robinson VM, Xue X, Yang L, Kowey PR, Yan GX. Mexiletine Prevents Recurrent Torsades?de?Pointes in Acquired Long?QT?Syndrome Refractory to Conventional Measures. JACC Clin Electrophysiol. 2015 Aug; 1(4):315-322. PMID: 29759319.
      Citations:    
    153. Freeman JV, Simon DN, Go AS, Spertus J, Fonarow GC, Gersh BJ, Hylek EM, Kowey PR, Mahaffey KW, Thomas LE, Chang P, Peterson ED, Piccini JP. Association Between Atrial Fibrillation Symptoms, Quality of Life, and Patient Outcomes: Results From the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF). Circ Cardiovasc Qual Outcomes. 2015 Jul; 8(4):393-402. PMID: 26058720.
      Citations:    
    154. Holmqvist F, Simon D, Steinberg BA, Hong SJ, Kowey PR, Reiffel JA, Naccarelli GV, Chang P, Gersh BJ, Peterson ED, Piccini JP. Catheter Ablation of Atrial Fibrillation in U.S. Community Practice--Results From Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF). J Am Heart Assoc. 2015 May 21; 4(5). PMID: 25999401.
      Citations:    
    155. O'Brien EC, Kim S, Hess PL, Kowey PR, Fonarow GC, Piccini JP, Peterson ED. Effect of the 2014 atrial fibrillation guideline revisions on the proportion of patients recommended for oral anticoagulation. JAMA Intern Med. 2015 May; 175(5):848-50. PMID: 25730606.
      Citations:    
    156. Pokorney SD, Simon DN, Thomas L, Fonarow GC, Kowey PR, Chang P, Singer DE, Ansell J, Blanco RG, Gersh B, Mahaffey KW, Hylek EM, Go AS, Piccini JP, Peterson ED. Patients' time in therapeutic range on warfarin among US patients with atrial fibrillation: Results from ORBIT-AF registry. Am Heart J. 2015 Jul; 170(1):141-8, 148.e1. PMID: 26093875.
      Citations:    
    157. Sarich TC, Seltzer JH, Berkowitz SD, Costin' J, Curnutte JT, Gibson CM, Hoffman M, Kaminskas E, Krucoff MW, Levy JH, Mintz PD, Reilly PA, Sager PT, Singer DE, Stockbridge N, Weitz JI, Kowey PR. Novel oral anticoagulants and reversal agents: Considerations for clinical development. Am Heart J. 2015 Jun; 169(6):751-7. PMID: 26027611.
      Citations:    
    158. Holmqvist F, Kim S, Steinberg BA, Reiffel JA, Mahaffey KW, Gersh BJ, Fonarow GC, Naccarelli GV, Chang P, Freeman JV, Kowey PR, Thomas L, Peterson ED, Piccini JP. Heart rate is associated with progression of atrial fibrillation, independent of rhythm. Heart. 2015 Jun; 101(11):894-9. PMID: 25732748.
      Citations:    
    159. Qi D, Yang Z, Robinson VM, Li J, Gao C, Guo D, Kowey PR, Yan GX. Heterogeneous distribution of INa-L determines interregional differences in rate adaptation of repolarization. Heart Rhythm. 2015 Jun; 12(6):1295-303. PMID: 25684234.
      Citations:    
    160. Dittrich HC, Feld GK, Bahnson TD, Camm AJ, Golitsyn S, Katz A, Koontz JI, Kowey PR, Waldo AL, Brown AM. COR-ART: A multicenter, randomized, double-blind, placebo-controlled dose-ranging study to evaluate single oral doses of vanoxerine for conversion of recent-onset atrial fibrillation or flutter to normal sinus rhythm. Heart Rhythm. 2015 Jun; 12(6):1105-12. PMID: 25684233.
      Citations:    
    161. Holmqvist F, Guan N, Zhu Z, Kowey PR, Allen LA, Fonarow GC, Hylek EM, Mahaffey KW, Freeman JV, Chang P, Holmes DN, Peterson ED, Piccini JP, Gersh BJ. Impact of obstructive sleep apnea and continuous positive airway pressure therapy on outcomes in patients with atrial fibrillation-Results from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF). Am Heart J. 2015 May; 169(5):647-654.e2. PMID: 25965712.
      Citations:    
    162. Hanley CM, Kowey PR. Are the novel anticoagulants better than warfarin for patients with atrial fibrillation? J Thorac Dis. 2015 Feb; 7(2):165-71. PMID: 25713732.
      Citations:    
    163. Sager PT, Seltzer J, Turner JR, Anderson JL, Hiatt WR, Kowey P, Prochaska JJ, Stockbridge N, White WB. Cardiovascular Safety Outcome Trials: A meeting report from the Cardiac Safety Research Consortium. Am Heart J. 2015 Apr; 169(4):486-95. PMID: 25819855.
      Citations:    
    164. Steinberg BA, Peterson ED, Kim S, Thomas L, Gersh BJ, Fonarow GC, Kowey PR, Mahaffey KW, Sherwood MW, Chang P, Piccini JP, Ansell J. Use and outcomes associated with bridging during anticoagulation interruptions in patients with atrial fibrillation: findings from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF). Circulation. 2015 Feb 03; 131(5):488-94. PMID: 25499873.
      Citations:    
    165. Guerra F, Hohnloser SH, Kowey PR, Crijns HJ, Aliot EM, Radzik D, Roy D, Connolly S, Capucci A. Efficacy and safety of dronedarone in patients previously treated with other antiarrhythmic agents. Clin Cardiol. 2014 Dec; 37(12):717-24. PMID: 25470298.
      Citations:    
    166. Ha AC, Breithardt G, Camm AJ, Crijns HJ, Fitzmaurice GM, Kowey PR, Le Heuzey JY, Naditch-Br?l? L, Prystowsky EN, Schwartz PJ, Torp-Pedersen C, Weintraub WS, Dorian P. Health-related quality of life in patients with atrial fibrillation treated with rhythm control versus rate control: insights from a prospective international registry (Registry on Cardiac Rhythm Disorders Assessing the Control of Atrial Fibrillation: RECORD-AF). Circ Cardiovasc Qual Outcomes. 2014 Nov; 7(6):896-904. PMID: 25387780.
      Citations:    
    167. Sardar MR, Badri M, Prince CT, Seltzer J, Kowey PR. Underrepresentation of women, elderly patients, and racial minorities in the randomized trials used for cardiovascular guidelines. JAMA Intern Med. 2014 Nov; 174(11):1868-70. PMID: 25264856.
      Citations:    
    168. Naccarelli GV, Kowey PR. The role of dronedarone in the treatment of atrial fibrillation/flutter in the aftermath of PALLAS. Curr Cardiol Rev. 2014 Nov; 10(4):303-8. PMID: 24821656.
      Citations:    
    169. Arkin JM, Kowey PR. Does atrial fibrillation pattern affect stroke risk? Data dredging to help the clinician. Eur Heart J. 2015 Feb 01; 36(5):265-6. PMID: 25354518.
      Citations:    
    170. Badri M, Abdelbaky A, Yan GX, Kowey PR. The impact of medical malpractice litigation on cardiovascular practice in the US and China. Int J Cardiol. 2014 Nov 15; 177(1):48-50. PMID: 25499337.
      Citations:    
    171. Garton AB, Dudzinski J, Kowey PR. Oral anticoagulant use around the time of atrial fibrillation ablation: a review of the current evidence of individual oral anticoagulant use for periprocedural atrial fibrillation ablation thromboembolic prophylaxis. J Cardiovasc Electrophysiol. 2014 Dec; 25(12):1411-8. PMID: 25216104.
      Citations:    
    172. Kowey PR, Rothman SA. In memoriam tribute to Dusan Z. Kocovic, MD. Circ Arrhythm Electrophysiol. 2014 Oct; 7(5):990. PMID: 25336373.
      Citations:    
    173. Sardar MR, Saeed W, Kowey PR. Antiarrhythmic drug therapy for atrial fibrillation. Cardiol Clin. 2014 Nov; 32(4):533-49. PMID: 25443235.
      Citations:    
    174. Zhang L, Mmagu O, Liu L, Li D, Fan Y, Baranchuk A, Kowey PR. Hypertrophic cardiomyopathy: Can the noninvasive diagnostic testing identify high risk patients? World J Cardiol. 2014 Aug 26; 6(8):764-70. PMID: 25228955.
      Citations:    
    175. Hanley CM, Esberg D, Kowey PR. Ablation versus drugs: what is the best first-line therapy for paroxysmal atrial fibrillation? Antiarrhythmic drugs are outmoded and catheter ablation should be the first-line option for all patients with paroxysmal atrial fibrillation: con. Circ Arrhythm Electrophysiol. 2014 Aug; 7(4):747-54. PMID: 25140020.
      Citations:    
    176. Zhang L, Liu L, Kowey PR, Fontaine GH. The electrocardiographic manifestations of arrhythmogenic right ventricular dysplasia. Curr Cardiol Rev. 2014 Aug; 10(3):237-45. PMID: 24827798.
      Citations:    
    177. Hanley CM, Esberg D, Kowey PR. Response to Pasquale Santangeli, MD, Luigi Di Biase, MD, PhD, Andrea Natale, MD. Circ Arrhythm Electrophysiol. 2014 Aug; 7(4):746. PMID: 25279401.
      Citations:    
    178. O'Brien EC, Simon DN, Allen LA, Singer DE, Fonarow GC, Kowey PR, Thomas LE, Ezekowitz MD, Mahaffey KW, Chang P, Piccini JP, Peterson ED. Reasons for warfarin discontinuation in the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF). Am Heart J. 2014 Oct; 168(4):487-94. PMID: 25262258.
      Citations:    
    179. Steinberg BA, Blanco RG, Ollis D, Kim S, Holmes DN, Kowey PR, Fonarow GC, Ansell J, Gersh B, Go AS, Hylek E, Mahaffey KW, Thomas L, Chang P, Peterson ED, Piccini JP. Outcomes Registry for Better Informed Treatment of Atrial Fibrillation II: rationale and design of the ORBIT-AF II registry. Am Heart J. 2014 Aug; 168(2):160-7. PMID: 25066554.
      Citations:    
    180. Steinberg BA, Kim S, Thomas L, Fonarow GC, Hylek E, Ansell J, Go AS, Chang P, Kowey P, Gersh BJ, Mahaffey KW, Singer DE, Piccini JP, Peterson ED. Lack of concordance between empirical scores and physician assessments of stroke and bleeding risk in atrial fibrillation: results from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF) registry. Circulation. 2014 May 20; 129(20):2005-12. PMID: 24682387.
      Citations:    
    181. Kowey PR, Roberts WC. Peter Russell Kowey, MD: a conversation with the editor. Am J Cardiol. 2014 Jun 01; 113(11):1917-32. PMID: 24837274.
      Citations:    
    182. Lenihan DJ, Kowey PR. In reply. Oncologist. 2014 Mar; 19(3):307. PMID: 24643717.
      Citations:    
    183. Steinberg BA, Kim S, Fonarow GC, Thomas L, Ansell J, Kowey PR, Mahaffey KW, Gersh BJ, Hylek E, Naccarelli G, Go AS, Reiffel J, Chang P, Peterson ED, Piccini JP. Drivers of hospitalization for patients with atrial fibrillation: Results from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF). Am Heart J. 2014 May; 167(5):735-42.e2. PMID: 24766985.
      Citations:    
    184. Sager PT, Kowey P. The thorough QT study: Is its demise on the horizon? Ann Noninvasive Electrocardiol. 2014 Jan; 19(1):1-3. PMID: 24397828.
      Citations:    
    185. O'Brien EC, Holmes DN, Ansell JE, Allen LA, Hylek E, Kowey PR, Gersh BJ, Fonarow GC, Koller CR, Ezekowitz MD, Mahaffey KW, Chang P, Peterson ED, Piccini JP, Singer DE. Physician practices regarding contraindications to oral anticoagulation in atrial fibrillation: findings from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF) registry. Am Heart J. 2014 Apr; 167(4):601-609.e1. PMID: 24655711.
      Citations:    
    186. Ice DS, Shapiro TA, Gnall EM, Kowey PR. Unanswered questions in patients with concurrent atrial fibrillation and acute coronary syndrome. Am J Cardiol. 2014 Mar 01; 113(5):888-96. PMID: 24528617.
      Citations:    
    187. Steinberg BA, Holmes DN, Piccini JP, Ansell J, Chang P, Fonarow GC, Gersh B, Mahaffey KW, Kowey PR, Ezekowitz MD, Singer DE, Thomas L, Peterson ED, Hylek EM. Early adoption of dabigatran and its dosing in US patients with atrial fibrillation: results from the outcomes registry for better informed treatment of atrial fibrillation. J Am Heart Assoc. 2013 Nov 25; 2(6):e000535. PMID: 24275632.
      Citations:    
    188. Rao P, Kowey PR. Drug-induced long-QT syndrome and torsade de pointes: an underrated problem? Europace. 2014 Jan; 16(1):4-5. PMID: 24192322.
      Citations:    
    189. Reiffel J, Verma A, Halperin JL, Gersh B, Tombul S, Carrithers J, Sherfesee L, Kowey P. Rationale and design of REVEAL AF: a prospective study of previously undiagnosed atrial fibrillation as documented by an insertable cardiac monitor in high-risk patients. Am Heart J. 2014 Jan; 167(1):22-7. PMID: 24332138.
      Citations:    
    190. Khaji A, Zhang L, Kowey P, Martinez-Lage M, Kocovic D. Mega-epsilon waves on 12-lead ECG--just another case of arrhythmogenic right ventricular dysplasia/cardiomyopathy? J Electrocardiol. 2013 Nov-Dec; 46(6):524-7. PMID: 24016846.
      Citations:    
    191. White WB, Cooke GE, Kowey PR, Calverley PMA, Bredenbr?ker D, Goehring UM, Zhu H, Lakkis H, Mosberg H, Rowe P, Rabe KF. Cardiovascular safety in patients receiving roflumilast for the treatment of COPD. Chest. 2013 Sep; 144(3):758-765. PMID: 23412642.
      Citations:    
    192. Badri M, Goldstein MA, Burke JF, Kowey PR. Reversal of fortunes: recognizing misplacement of ECG electrodes. Am J Med. 2013 Oct; 126(10):868-70. PMID: 23932162.
      Citations:    
    193. Lenihan DJ, Kowey PR. Overview and management of cardiac adverse events associated with tyrosine kinase inhibitors. Oncologist. 2013; 18(8):900-8. PMID: 23918069.
      Citations:    
    194. Mohammed I, Syed W, Kowey PR. Oral anticoagulants to reduce the risk of stroke in atrial fibrillation: how should a clinician choose? Clin Cardiol. 2013 Nov; 36(11):663-70. PMID: 23893881.
      Citations:    
    195. Fosbol EL, Holmes DN, Piccini JP, Thomas L, Reiffel JA, Mills RM, Kowey P, Mahaffey K, Gersh BJ, Peterson ED. Provider specialty and atrial fibrillation treatment strategies in United States community practice: findings from the ORBIT-AF registry. J Am Heart Assoc. 2013 Jul 18; 2(4):e000110. PMID: 23868192.
      Citations:    
    196. Steinberg BA, Kim S, Piccini JP, Fonarow GC, Lopes RD, Thomas L, Ezekowitz MD, Ansell J, Kowey P, Singer DE, Gersh B, Mahaffey KW, Hylek E, Go AS, Chang P, Peterson ED. Use and associated risks of concomitant aspirin therapy with oral anticoagulation in patients with atrial fibrillation: insights from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF) Registry. Circulation. 2013 Aug 13; 128(7):721-8. PMID: 23861512.
      Citations:    
    197. Hess PL, Kim S, Piccini JP, Allen LA, Ansell JE, Chang P, Freeman JV, Gersh BJ, Kowey PR, Mahaffey KW, Thomas L, Peterson ED, Fonarow GC. Use of evidence-based cardiac prevention therapy among outpatients with atrial fibrillation. Am J Med. 2013 Jul; 126(7):625-32.e1. PMID: 23787195.
      Citations:    
    198. Cullen MW, Kim S, Piccini JP, Ansell JE, Fonarow GC, Hylek EM, Singer DE, Mahaffey KW, Kowey PR, Thomas L, Go AS, Lopes RD, Chang P, Peterson ED, Gersh BJ. Risks and benefits of anticoagulation in atrial fibrillation: insights from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF) registry. Circ Cardiovasc Qual Outcomes. 2013 Jul; 6(4):461-9. PMID: 23759473.
      Citations:    
    199. Goldstein MA, Badri M, Kocovic D, Kowey PR. Electrical failure of an ICD lead due to a presumed insulation defect only diagnosed by a maximum output shock. Pacing Clin Electrophysiol. 2013 Sep; 36(9):1068-71. PMID: 23731252.
      Citations:    
    200. Zhang YY, Qiu C, Davis PJ, Jhaveri M, Prystowsky EN, Kowey P, Weintraub WS. Predictors of progression of recently diagnosed atrial fibrillation in REgistry on Cardiac Rhythm DisORDers Assessing the Control of Atrial Fibrillation (RecordAF)-United States cohort. Am J Cardiol. 2013 Jul 01; 112(1):79-84. PMID: 23561591.
      Citations:    
    201. Kowey PR, Naccarelli GV. The reply. Am J Med. 2013 Apr; 126(4):e23. PMID: 23507215.
      Citations:    
    202. Steinberg BA, Holmes DN, Ezekowitz MD, Fonarow GC, Kowey PR, Mahaffey KW, Naccarelli G, Reiffel J, Chang P, Peterson ED, Piccini JP. Rate versus rhythm control for management of atrial fibrillation in clinical practice: results from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF) registry. Am Heart J. 2013 Apr; 165(4):622-9. PMID: 23537981.
      Citations:    
    203. Sager P, Heilbraun J, Turner JR, Gintant G, Geiger MJ, Kowey PR, Mansoor GA, Mendzelevski B, Michelson EL, Stockbridge N, Weber MA, White WB. Assessment of drug-induced increases in blood pressure during drug development: report from the Cardiac Safety Research Consortium. Am Heart J. 2013 Apr; 165(4):477-88. PMID: 23537963.
      Citations:    
    204. Immordino L, Connolly S, Crijns H, Roy D, Capucci A, Radzik D, Aliot E, Hohnloser S, Kowey P. Effects of dronedarone started rapidly after amiodarone discontinuation. Clin Cardiol. 2013 Feb; 36(2):88-95. PMID: 23338943.
      Citations:    
    205. Robinson VM, Kowey PR. Should Physicians Continue to Recommend Fish Oil for Patients with Atrial Fibrillation? J Atr Fibrillation. 2012 Oct-Nov; 5(3):593. PMID: 28496771.
      Citations:    
    206. Liu T, Traebert M, Ju H, Suter W, Guo D, Hoffmann P, Kowey PR, Yan GX. Differentiating electrophysiological effects and cardiac safety of drugs based on the electrocardiogram: a blinded validation. Heart Rhythm. 2012 Oct; 9(10):1706-15. PMID: 22710481.
      Citations:    
    207. Kowey PR, Naccarelli GV. The Food and Drug Administration decision not to approve the 110 mg dose of dabigatran: give us a way out. Am J Med. 2012 Aug; 125(8):732. PMID: 22608987.
      Citations:    
    208. De Vos CB, Breithardt G, Camm AJ, Dorian P, Kowey PR, Le Heuzey JY, Naditch-Br?l? L, Prystowsky EN, Schwartz PJ, Torp-Pedersen C, Weintraub WS, Crijns HJ. Progression of atrial fibrillation in the REgistry on Cardiac rhythm disORDers assessing the control of Atrial Fibrillation cohort: clinical correlates and the effect of rhythm-control therapy. Am Heart J. 2012 May; 163(5):887-93. PMID: 22607868.
      Citations:    
    209. Mohammed I, Mohmand-Borkowski A, Burke JF, Kowey PR. Stroke prevention in atrial fibrillation. J Cardiovasc Med (Hagerstown). 2012 Feb; 13(2):73-85. PMID: 22193836.
      Citations:    
    210. Cushing DJ, Souney PF, Cooper WD, Mosher GL, Adams MP, Machatha S, Zhang B, Kowey PR. Pharmacokinetics and platelet aggregation inhibitory effects of a novel intravenous formulation of clopidogrel in humans. Clin Exp Pharmacol Physiol. 2012 Jan; 39(1):3-8. PMID: 21933229.
      Citations:    
    211. Khitri AR, Aliot EM, Capucci A, Connolly SJ, Crijns H, Hohnloser SH, Kulakowski P, Roy D, Radzik D, Kowey PR. Celivarone for maintenance of sinus rhythm and conversion of atrial fibrillation/flutter. J Cardiovasc Electrophysiol. 2012 May; 23(5):462-72. PMID: 22171925.
      Citations:    
    212. Kowey PR, Crijns HJ, Aliot EM, Capucci A, Kulakowski P, Radzik D, Roy D, Connolly SJ, Hohnloser SH. Efficacy and safety of celivarone, with amiodarone as calibrator, in patients with an implantable cardioverter-defibrillator for prevention of implantable cardioverter-defibrillator interventions or death: the ALPHEE study. Circulation. 2011 Dec 13; 124(24):2649-60. PMID: 22082672.
      Citations:    
    213. Kowey PR. What's a mother to do? J Cardiovasc Electrophysiol. 2012 Mar; 23(3):269-70. PMID: 21985438.
      Citations:    
    214. Gojkovic O, Aliot EM, Capucci A, Connolly SJ, Crijns H, Hohnloser SH, Kulakowski P, Roy D, Radzik D, Singh BN, Kowey PR. Celivarone in patients with an implantable cardioverter-defibrillator: adjunctive therapy for the reduction of ventricular arrhythmia-triggered implantable cardioverter-defibrillator interventions. Heart Rhythm. 2012 Feb; 9(2):217-224.e2. PMID: 21978965.
      Citations:    
    215. Piccini JP, Fraulo ES, Ansell JE, Fonarow GC, Gersh BJ, Go AS, Hylek EM, Kowey PR, Mahaffey KW, Thomas LE, Kong MH, Lopes RD, Mills RM, Peterson ED. Outcomes registry for better informed treatment of atrial fibrillation: rationale and design of ORBIT-AF. Am Heart J. 2011 Oct; 162(4):606-612.e1. PMID: 21982650.
      Citations:    
    216. Camm AJ, Breithardt G, Crijns H, Dorian P, Kowey P, Le Heuzey JY, Merioua I, Pedrazzini L, Prystowsky EN, Schwartz PJ, Torp-Pedersen C, Weintraub W. Real-life observations of clinical outcomes with rhythm- and rate-control therapies for atrial fibrillation RECORDAF (Registry on Cardiac Rhythm Disorders Assessing the Control of Atrial Fibrillation). J Am Coll Cardiol. 2011 Jul 26; 58(5):493-501. PMID: 21777747.
      Citations:    
    217. Kowey PR. Thoroughly measuring the QT interval: can we find the shortcuts? Heart Rhythm. 2011 Nov; 8(11):1786-7. PMID: 21762671.
      Citations:    
    218. Kowey PR. A piece of my mind. The silent majority. JAMA. 2011 Jul 06; 306(1):18-9. PMID: 21730231.
      Citations:    
    219. Droogan C, Patel C, Yan GX, Kowey PR. Role of antiarrhythmic drugs: frequent implantable cardioverter-defibrillator shocks, risk of proarrhythmia, and new drug therapy. Heart Fail Clin. 2011 Apr; 7(2):195-205, viii. PMID: 21439498.
      Citations:    
    220. Patel C, Salahuddin M, Jones A, Patel A, Yan GX, Kowey PR. Atrial fibrillation: pharmacological therapy. Curr Probl Cardiol. 2011 Mar; 36(3):87-120. PMID: 21392636.
      Citations:    
    221. Kowey PR. How much has malpractice litigation altered the care of cardiac rhythm patients? J Cardiovasc Electrophysiol. 2011 Apr; 22(4):488-9. PMID: 21332869.
      Citations:    
    222. Kowey PR, Mudumbi RV, Aquilina JW, DiBattiste PM. Cardiovascular safety profile of dapoxetine during the premarketing evaluation. Drugs R D. 2011; 11(1):1-11. PMID: 21410293.
      Citations:    
    223. Guo D, Liu Q, Liu T, Elliott G, Gingras M, Kowey PR, Yan GX. Electrophysiological properties of HBI-3000: a new antiarrhythmic agent with multiple-channel blocking properties in human ventricular myocytes. J Cardiovasc Pharmacol. 2011 Jan; 57(1):79-85. PMID: 20980921.
      Citations:    
    224. Guo D, Lian J, Liu T, Cox R, Margulies KB, Kowey PR, Yan GX. Contribution of late sodium current (I(Na-L)) to rate adaptation of ventricular repolarization and reverse use-dependence of QT-prolonging agents. Heart Rhythm. 2011 May; 8(5):762-9. PMID: 21184845.
      Citations:    
    225. Sun Y, Quan XQ, Fromme S, Cox RH, Zhang P, Zhang L, Guo D, Guo J, Patel C, Kowey PR, Yan GX. A novel mutation in the KCNH2 gene associated with short QT syndrome. J Mol Cell Cardiol. 2011 Mar; 50(3):433-41. PMID: 21130771.
      Citations:    
    226. Kowey PR, Reiffel JA, Ellenbogen KA, Naccarelli GV, Pratt CM. Efficacy and safety of prescription omega-3 fatty acids for the prevention of recurrent symptomatic atrial fibrillation: a randomized controlled trial. JAMA. 2010 Dec 01; 304(21):2363-72. PMID: 21078810.
      Citations:    
    227. Kowey PR. Why did you order that echocardiogram? Clin Cardiol. 2010 Oct; 33(10):596-597. PMID: 20960533.
      Citations:    
    228. Al-Khatib SM, Calkins H, Eloff BC, Kowey P, Hammill SC, Ellenbogen KA, Marinac-Dabic D, Waldo AL, Brindis RG, Wilbur DJ, Jackman WM, Yaross MS, Russo AM, Prystowsky E, Varosy PD, Gross T, Pinnow E, Turakhia MP, Krucoff MW. Developing the Safety of Atrial Fibrillation Ablation Registry Initiative (SAFARI) as a collaborative pan-stakeholder critical path registry model: a Cardiac Safety Research Consortium "Incubator" Think Tank. Am Heart J. 2010 Oct; 160(4):619-26. PMID: 20934554.
      Citations:    
    229. Kowey PR, Naccarelli GV. Preface Advances in Antiarrhythmic Drug Therapy. Card Electrophysiol Clin. 2010 Sep; 2(3):xiii. PMID: 28770807.
      Citations:    
    230. Link MG, Yan GX, Kowey PR. Evaluation of toxicity for heart failure therapeutics: studying effects on the QT interval. Circ Heart Fail. 2010 Jul; 3(4):547-55. PMID: 20647490.
      Citations:    
    231. Min SS, Turner JR, Nada A, DiMino TL, Hynie I, Kleiman R, Kowey P, Krucoff MW, Mason JW, Phipps A, Newton-Cheh C, Pordy R, Strnadova C, Targum S, Uhl K, Finkle J. Evaluation of ventricular arrhythmias in early clinical pharmacology trials and potential consequences for later development. Am Heart J. 2010 May; 159(5):716-29. PMID: 20435178.
      Citations:    
    232. Lian J, Yan GX, Kowey PR. Born to be bradycardic? Cardiology. 2010; 115(3):229-31. PMID: 20299796.
      Citations:    
    233. Kowey PR, Breithardt G, Camm J, Crijns H, Dorian P, Le Heuzey JY, Pedrazzini L, Prystowsky EN, Salette G, Schwartz PJ, Torp-Pedersen C, Weintraub W. Physician stated atrial fibrillation management in light of treatment guidelines: data from an international, observational prospective survey. Clin Cardiol. 2010 Mar; 33(3):172-8. PMID: 20235224.
      Citations:    
    234. Guo D, Young L, Wu Y, Belardinelli L, Kowey PR, Yan GX. Increased late sodium current in left atrial myocytes of rabbits with left ventricular hypertrophy: its role in the genesis of atrial arrhythmias. Am J Physiol Heart Circ Physiol. 2010 May; 298(5):H1375-81. PMID: 20190097.
      Citations:    
    235. Reiffel JA, Kowey PR, Myerburg R, Naccarelli GV, Packer DL, Pratt CM, Reiter MJ, Waldo AL. Practice patterns among United States cardiologists for managing adults with atrial fibrillation (from the AFFECTS Registry). Am J Cardiol. 2010 Apr 15; 105(8):1122-9. PMID: 20381664.
      Citations:    
    236. Kowey PR, Reiffel JA, Myerburg R, Naccarelli GV, Packer DL, Pratt CM, Reiter MJ, Waldo AL. Warfarin and aspirin use in atrial fibrillation among practicing cardiologist (from the AFFECTS Registry). Am J Cardiol. 2010 Apr 15; 105(8):1130-4. PMID: 20381665.
      Citations:    
    237. Mohammed KS, Kowey PR, Musco S. Adjuvant therapy for atrial fibrillation. Future Cardiol. 2010 Jan; 6(1):67-81. PMID: 20014988.
      Citations:    
    238. Al-Khatib SM, Calkins H, Eloff BC, Packer DL, Ellenbogen KA, Hammill SC, Natale A, Page RL, Prystowsky E, Jackman WM, Stevenson WG, Waldo AL, Wilber D, Kowey P, Yaross MS, Mark DB, Reiffel J, Finkle JK, Marinac-Dabic D, Pinnow E, Sager P, Sedrakyan A, Canos D, Gross T, Berliner E, Krucoff MW. Planning the Safety of Atrial Fibrillation Ablation Registry Initiative (SAFARI) as a Collaborative Pan-Stakeholder Critical Path Registry Model: a Cardiac Safety Research Consortium "Incubator" Think Tank. Am Heart J. 2010 Jan; 159(1):17-24. PMID: 20102862.
      Citations:    
    239. Le Heuzey JY, Breithardt G, Camm J, Crijns H, Dorian P, Kowey PR, Merioua I, Prystowsky EN, Schwartz PJ, Torp-Pedersen C, Weintraub W. The RecordAF study: design, baseline data, and profile of patients according to chosen treatment strategy for atrial fibrillation. Am J Cardiol. 2010 Mar 01; 105(5):687-93. PMID: 20185018.
      Citations:    
    240. Patel C, Yan GX, Kocovic D, Kowey PR. Should catheter ablation be the preferred therapy for reducing ICD shocks?: Ventricular tachycardia ablation versus drugs for preventing ICD shocks: role of adjuvant antiarrhythmic drug therapy. Circ Arrhythm Electrophysiol. 2009 Dec; 2(6):705-11; discussion 712. PMID: 20009081.
      Citations:    
    241. Kowey PR, Dorian P, Mitchell LB, Pratt CM, Roy D, Schwartz PJ, Sadowski J, Sobczyk D, Bochenek A, Toft E. Vernakalant hydrochloride for the rapid conversion of atrial fibrillation after cardiac surgery: a randomized, double-blind, placebo-controlled trial. Circ Arrhythm Electrophysiol. 2009 Dec; 2(6):652-9. PMID: 19948506.
      Citations:    
    242. Cushing DJ, Adams MP, Cooper WD, Zhang B, Lipicky RJ, Kowey PR. Evaluation of the effects of PM101, a cyclodextrin-based formulation of intravenous amiodarone, on blood pressure in healthy humans. Am J Cardiol. 2009 Oct 15; 104(8):1152-7. PMID: 19801040.
      Citations:    
    243. Patel C, Yan GX, Kowey PR. Dronedarone. Circulation. 2009 Aug 18; 120(7):636-44. PMID: 19687370.
      Citations:    
    244. Pratt CM, Reiffel JA, Ellenbogen KA, Naccarelli GV, Kowey PR. Efficacy and safety of prescription omega-3-acid ethyl esters for the prevention of recurrent symptomatic atrial fibrillation: a prospective study. Am Heart J. 2009 Aug; 158(2):163-169.e1-3. PMID: 19619690.
      Citations:    
    245. Cushing DJ, Cooper WD, Gralinski MR, Lipicky RJ, Kudenchuk PJ, Kowey PR. Comparison of the cardiac electrophysiology and general toxicology of two formulations of intravenous amiodarone in dogs. Cardiovasc Toxicol. 2009 Sep; 9(3):126-33. PMID: 19554478.
      Citations:    
    246. Rock EP, Finkle J, Fingert HJ, Booth BP, Garnett CE, Grant S, Justice RL, Kovacs RJ, Kowey PR, Rodriguez I, Sanhai WR, Strnadova C, Targum SL, Tsong Y, Uhl K, Stockbridge N. Assessing proarrhythmic potential of drugs when optimal studies are infeasible. Am Heart J. 2009 May; 157(5):827-36, 836.e1. PMID: 19376308.
      Citations:    
    247. Sarapa N, Gussak I, Vajdic B, George S, Hadzievski L, Francom SF, Kowey P. Comparison of QTinno, a fully automated electrocardiographic analysis program, to semiautomated electrocardiographic analysis methods in a drug safety study in healthy subjects. J Electrocardiol. 2009 Jul-Aug; 42(4):358-66. PMID: 19362316.
      Citations:    
    248. Link M, Kowey P. One small step. Pacing Clin Electrophysiol. 2009 Mar; 32(3):291-3. PMID: 19272056.
      Citations:    
    249. Cushing DJ, Adams MP, Cooper WD, Kowey PR, Lipicky RJ. Bioequivalence of 2 intravenous amiodarone formulations in healthy participants. J Clin Pharmacol. 2009 Apr; 49(4):407-15. PMID: 19246726.
      Citations:    
    250. Cushing DJ, Kowey PR, Cooper WD, Massey BW, Gralinski MR, Lipicky RJ. PM101: a cyclodextrin-based intravenous formulation of amiodarone devoid of adverse hemodynamic effects. Eur J Pharmacol. 2009 Apr 01; 607(1-3):167-72. PMID: 19232340.
      Citations:    
    251. Patel C, Burke JF, Patel H, Gupta P, Kowey PR, Antzelevitch C, Yan GX. Is there a significant transmural gradient in repolarization time in the intact heart? Cellular basis of the T wave: a century of controversy. Circ Arrhythm Electrophysiol. 2009 Feb; 2(1):80-8. PMID: 19808446.
      Citations:    
    252. Conway EL, Musco S, Kowey PR. Drug therapy for atrial fibrillation. Cardiol Clin. 2009 Feb; 27(1):109-23, ix. PMID: 19111768.
      Citations:    
    253. Zhu TG, Patel C, Martin S, Quan X, Wu Y, Burke JF, Chernick M, Kowey PR, Yan GX. Ventricular transmural repolarization sequence: its relationship with ventricular relaxation and role in ventricular diastolic function. Eur Heart J. 2009 Feb; 30(3):372-80. PMID: 19147608.
      Citations:    
    254. Laughlin JC, Kowey PR. Dronedarone: a new treatment for atrial fibrillation. J Cardiovasc Electrophysiol. 2008 Nov; 19(11):1220-6. PMID: 18702618.
      Citations:    
    255. Dorian P, Al-Khalidi HR, Hohnloser SH, Brum JM, Dunnmon PM, Pratt CM, Holroyde MJ, Kowey P. Azimilide reduces emergency department visits and hospitalizations in patients with an implantable cardioverter-defibrillator in a placebo-controlled clinical trial. J Am Coll Cardiol. 2008 Sep 23; 52(13):1076-83. PMID: 18848141.
      Citations:    
    256. Conway E, Musco S, Kowey PR. New horizons in antiarrhythmic therapy: will novel agents overcome current deficits? Am J Cardiol. 2008 Sep 22; 102(6A):12H-19H. PMID: 18790110.
      Citations:    
    257. Bangalore S, Messerli FH, Cohen JD, Bacher PH, Sleight P, Mancia G, Kowey P, Zhou Q, Champion A, Pepine CJ. Verapamil-sustained release-based treatment strategy is equivalent to atenolol-based treatment strategy at reducing cardiovascular events in patients with prior myocardial infarction: an INternational VErapamil SR-Trandolapril (INVEST) substudy. Am Heart J. 2008 Aug; 156(2):241-7. PMID: 18657652.
      Citations:    
    258. Guo D, Young L, Patel C, Jiao Z, Wu Y, Liu T, Kowey PR, Yan GX. Calcium-activated chloride current contributes to action potential alternations in left ventricular hypertrophy rabbit. Am J Physiol Heart Circ Physiol. 2008 Jul; 295(1):H97-H104. PMID: 18441200.
      Citations:    
    259. McCurdy R, Kowey PR. Boldly monitoring where few people have monitored before. Cardiology. 2008; 111(4):237-8. PMID: 18434731.
      Citations:    
    260. Kowey PR, Wenger NK, Weber MA, Lavie CJ. The geriatric paradox. Am J Geriatr Cardiol. 2008 Mar-Apr; 17(2):69-70. PMID: 18326942.
      Citations:    
    261. Prystowsky EN, Ja?s P, Kowey P, Nattel S, Ruskin JN. Case studies with the experts: management decisions in atrial fibrillation. J Cardiovasc Electrophysiol. 2008 Feb; 19 Suppl 1:S1-12; quiz S13-5. PMID: 18226097.
      Citations:    
    262. Musco S, Conway EL, Kowey PR. Drug therapy for atrial fibrillation. Med Clin North Am. 2008 Jan; 92(1):121-41, xi. PMID: 18061001.
      Citations:    
    263. Kowey PR, Yan GX. Discarding the baby with the bathwater. Pacing Clin Electrophysiol. 2007 Dec; 30(12):1429-31. PMID: 18070294.
      Citations:    
    264. Guo D, Zhou J, Zhao X, Gupta P, Kowey PR, Martin J, Wu Y, Liu T, Yan GX. L-type calcium current recovery versus ventricular repolarization: preserved membrane-stabilizing mechanism for different QT intervals across species. Heart Rhythm. 2008 Feb; 5(2):271-9. PMID: 18242553.
      Citations:    
    265. Singh BN, Connolly SJ, Crijns HJ, Roy D, Kowey PR, Capucci A, Radzik D, Aliot EM, Hohnloser SH. Dronedarone for maintenance of sinus rhythm in atrial fibrillation or flutter. N Engl J Med. 2007 Sep 06; 357(10):987-99. PMID: 17804843.
      Citations:    
    266. Antzelevitch C, Sicouri S, Di Diego JM, Burashnikov A, Viskin S, Shimizu W, Yan GX, Kowey P, Zhang L. Does Tpeak-Tend provide an index of transmural dispersion of repolarization? Heart Rhythm. 2007 Aug; 4(8):1114-6; author reply 1116-9. PMID: 17675094.
      Citations:    
    267. Lally JA, Gnall EM, Seltzer J, Kowey PR. Non-antiarrhythmic drugs in atrial fibrillation: a review of non-antiarrhythmic agents in prevention of atrial fibrillation. J Cardiovasc Electrophysiol. 2007 Nov; 18(11):1222-8. PMID: 17553070.
      Citations:    
    268. Rothman SA, Laughlin JC, Seltzer J, Walia JS, Baman RI, Siouffi SY, Sangrigoli RM, Kowey PR. The diagnosis of cardiac arrhythmias: a prospective multi-center randomized study comparing mobile cardiac outpatient telemetry versus standard loop event monitoring. J Cardiovasc Electrophysiol. 2007 Mar; 18(3):241-7. PMID: 17318994.
      Citations:    
    269. Guo D, Zhao X, Wu Y, Liu T, Kowey PR, Yan GX. L-type calcium current reactivation contributes to arrhythmogenesis associated with action potential triangulation. J Cardiovasc Electrophysiol. 2007 Feb; 18(2):196-203. PMID: 17212595.
      Citations:    
    270. Kowey PR, Yan GX. The meta-analysis: supportive or illuminating? Eur Heart J. 2006 Dec; 27(23):2744-5. PMID: 17107979.
      Citations:    
    271. Musco S, Seltzer J, Kowey PR. Future directions in antiarrhythmic drug therapy for atrial fibrillation. Future Cardiol. 2006 Sep; 2(5):545-53. PMID: 19804191.
      Citations:    
    272. Triola BR, Kowey PR. Antiarrhythmic drug therapy. Curr Treat Options Cardiovasc Med. 2006 Sep; 8(5):362-70. PMID: 16939674.
      Citations:    
    273. Siddiqui A, Kowey PR. Sudden death secondary to cardiac arrhythmias: mechanisms and treatment strategies. Curr Opin Cardiol. 2006 Sep; 21(5):517-25. PMID: 16900017.
      Citations:    
    274. Rudo T, Kowey P. Atrial fibrillation: choosing an antiarrhythmic drug. Curr Cardiol Rep. 2006 Sep; 8(5):370-6. PMID: 16956453.
      Citations:    
    275. Olshansky B, Kowey PR, Naccarelli GV. Fast-track training of nonelectrophysiologists to implant defibrillators: is it needed? Pacing Clin Electrophysiol. 2006 Jun; 29(6):627-31. PMID: 16784429.
      Citations:    
    276. Kerr CR, Connolly SJ, Kowey P, Page RL, Pritchett EL, Ruda MY, Ruzyllo W, Wilkinson WE. Efficacy of azimilide for the maintenance of sinus rhythm in patients with paroxysmal atrial fibrillation in the presence and absence of structural heart disease. Am J Cardiol. 2006 Jul 15; 98(2):215-8. PMID: 16828595.
      Citations:    
    277. Pritchett EL, Kowey P, Connolly S, Page RL, Kerr C, Wilkinson WE. Antiarrhythmic efficacy of azimilide in patients with atrial fibrillation. Maintenance of sinus rhythm after conversion to sinus rhythm. Am Heart J. 2006 May; 151(5):1043-9. PMID: 16644334.
      Citations:    
    278. Liu T, Brown BS, Wu Y, Antzelevitch C, Kowey PR, Yan GX. Blinded validation of the isolated arterially perfused rabbit ventricular wedge in preclinical assessment of drug-induced proarrhythmias. Heart Rhythm. 2006 Aug; 3(8):948-56. PMID: 16876745.
      Citations:    
    279. Kowey PR, Yan GX. "Doctor, why didn't you tell me about this before the ICD?". J Cardiovasc Electrophysiol. 2006 Mar; 17(3):296-7. PMID: 16643404.
      Citations:    
    280. Pepine CJ, Kowey PR, Kupfer S, Kolloch RE, Benetos A, Mancia G, Coca A, Cooper-DeHoff RM, Handberg E, Gaxiola E, Sleight P, Conti CR, Hewkin AC, Tavazzi L. Predictors of adverse outcome among patients with hypertension and coronary artery disease. J Am Coll Cardiol. 2006 Feb 07; 47(3):547-51. PMID: 16458134.
      Citations:    
    281. Esberg D, Kowey P. Does "anti-lipid" also mean "anti-arrhythmic"? J Card Fail. 2005 Dec; 11(9):691-2. PMID: 16360964.
      Citations:    
    282. Jang IK, Pettigrew V, Picard MH, Kowey PR, Demmel V, Zile MR, Tatsuno J, Wackers FJ, Hibberd M. A randomized, double-blind, placebo-controlled study of the safety and efficacy of intravenous MCC-135 as an adjunct to primary percutaneous coronary intervention in patients with acute myocardial infarction: rationale and design of the evaluation of MCC-135 for left ventricular salvage in acute MI (EVOLVE) study. J Thromb Thrombolysis. 2005 Dec; 20(3):147-53. PMID: 16261287.
      Citations:    
    283. Rudo TJ, Kowey PR. Real-world algorithms for the optimal use of drugs and devices in the patient post myocardial infarction and the future of post myocardial infarction management. Clin Cardiol. 2005 Nov; 28(11 Suppl 1):I58-63. PMID: 16450814.
      Citations:    
    284. Carr AA, Kowey PR, Devereux RB, Brenner BM, Dahl?f B, Ibsen H, Lindholm LH, Lyle PA, Snapinn SM, Zhang Z, Edelman JM, Shahinfar S. Hospitalizations for new heart failure among subjects with diabetes mellitus in the RENAAL and LIFE studies. Am J Cardiol. 2005 Dec 01; 96(11):1530-6. PMID: 16310435.
      Citations:    
    285. Hlaing T, Guo D, Zhao X, DiMino T, Greenspon L, Kowey PR, Yan GX. The QT and Tp-e intervals in left and right chest leads: comparison between patients with systemic and pulmonary hypertension. J Electrocardiol. 2005 Oct; 38(4 Suppl):154-8. PMID: 16226092.
      Citations:    
    286. Kowey PR, Yan GX. Proarrhythmias and antiarrhythmias: two sides of the same coin. Heart Rhythm. 2005 Sep; 2(9):957-9. PMID: 16171750.
      Citations:    
    287. Kowey PR, Stoenescu ML. Selection of drugs in pursuit of a rhythm control strategy. Prog Cardiovasc Dis. 2005 Sep-Oct; 48(2):139-45. PMID: 16253653.
      Citations:    
    288. Kowey PR, Yan GX. Making a silk purse out of a sow's ear. J Am Coll Cardiol. 2005 Aug 16; 46(4):688-9. PMID: 16098436.
      Citations:    
    289. Wu Y, Carlsson L, Liu T, Kowey PR, Yan GX. Assessment of the proarrhythmic potential of the novel antiarrhythmic agent AZD7009 and dofetilide in experimental models of torsades de pointes. J Cardiovasc Electrophysiol. 2005 Aug; 16(8):898-904. PMID: 16101634.
      Citations:    
    290. Kowey PR. A review of carvedilol arrhythmia data in clinical trials. J Cardiovasc Pharmacol Ther. 2005 Jun; 10 Suppl 1:S59-68. PMID: 15965573.
      Citations:    
    291. Joshi AK, Kowey PR, Prystowsky EN, Benditt DG, Cannom DS, Pratt CM, McNamara A, Sangrigoli RM. First experience with a Mobile Cardiac Outpatient Telemetry (MCOT) system for the diagnosis and management of cardiac arrhythmia. Am J Cardiol. 2005 Apr 01; 95(7):878-81. PMID: 15781022.
      Citations:    
    292. Hlaing T, DiMino T, Kowey PR, Yan GX. ECG repolarization waves: their genesis and clinical implications. Ann Noninvasive Electrocardiol. 2005 Apr; 10(2):211-23. PMID: 15842434.
      Citations:    
    293. Kowey PR, Dickson TZ, Zhang Z, Shahinfar S, Brenner BM. Losartan and end-organ protection--lessons from the RENAAL study. Clin Cardiol. 2005 Mar; 28(3):136-42. PMID: 15813620.
      Citations:    
    294. Ross HM, Kocovic DZ, Kowey PR. Pharmacologic therapies for atrial fibrillation. Am J Geriatr Cardiol. 2005 Mar-Apr; 14(2):62-7. PMID: 15785145.
      Citations:    
    295. Cooper-DeHoff RM, Handberg EM, Cohen J, Kowey P, Messerli FH, Mancia G, Cangiano JL, Gaxiola E, Garcia-Barreto D, Hewkin AC, Pepine CJ. Characteristics of contemporary patients with hypertension and coronary artery disease. Clin Cardiol. 2004 Oct; 27(10):571-6. PMID: 15553310.
      Citations:    
    296. Kowey PR, Yannicelli D, Amsterdam E. Effectiveness of oral propafenone for the prevention of atrial fibrillation after coronary artery bypass grafting. Am J Cardiol. 2004 Sep 01; 94(5):663-5. PMID: 15342305.
      Citations:    
    297. Teng R, Sarich TC, Eriksson UG, Hamer JE, Gillette S, Sch?tzer KM, Carlson GF, Kowey PR. A pharmacokinetic study of the combined administration of amiodarone and ximelagatran, an oral direct thrombin inhibitor. J Clin Pharmacol. 2004 Sep; 44(9):1063-71. PMID: 15317834.
      Citations:    
    298. Wong J, Patel RA, Kowey PR. The clinical use of angiotensin-converting enzyme inhibitors. Prog Cardiovasc Dis. 2004 Sep-Oct; 47(2):116-30. PMID: 15586352.
      Citations:    
    299. Yan GX, Joshi A, Guo D, Hlaing T, Martin J, Xu X, Kowey PR. Phase 2 reentry as a trigger to initiate ventricular fibrillation during early acute myocardial ischemia. Circulation. 2004 Aug 31; 110(9):1036-41. PMID: 15302777.
      Citations:    
    300. Hohnloser SH, Dorian P, Straub M, Beckmann K, Kowey P. Safety and efficacy of intravenously administered tedisamil for rapid conversion of recent-onset atrial fibrillation or atrial flutter. J Am Coll Cardiol. 2004 Jul 07; 44(1):99-104. PMID: 15234416.
      Citations:    
    301. Joshi AK, Sljapic T, Borghei H, Kowey PR. Case of polymorphic ventricular tachycardia in diphenhydramine poisoning. J Cardiovasc Electrophysiol. 2004 May; 15(5):591-3. PMID: 15149431.
      Citations:    
    302. Kowey PR. You only get so many heartbeats... J Am Coll Cardiol. 2004 Apr 07; 43(7):1209-10. PMID: 15063431.
      Citations:    
    303. Pepine CJ, Handberg EM, Cooper-DeHoff RM, Marks RG, Kowey P, Messerli FH, Mancia G, Cangiano JL, Garcia-Barreto D, Keltai M, Erdine S, Bristol HA, Kolb HR, Bakris GL, Cohen JD, Parmley WW. A calcium antagonist vs a non-calcium antagonist hypertension treatment strategy for patients with coronary artery disease. The International Verapamil-Trandolapril Study (INVEST): a randomized controlled trial. JAMA. 2003 Dec 03; 290(21):2805-16. PMID: 14657064.
      Citations:    
    304. Kowey PR, Yan GX, Dimino TL, Kocovic DZ. Overview of the management of atrial fibrillation: what is the current state of the art? J Cardiovasc Electrophysiol. 2003 Dec; 14(12 Suppl):S275-80; discussion S280. PMID: 15005214.
      Citations:    
    305. Kowey PR. I've fallen and I can't get up. Am J Geriatr Cardiol. 2003 Sep-Oct; 12(5):306. PMID: 12963856.
      Citations:    
    306. Yan GX, Lankipalli RS, Burke JF, Musco S, Kowey PR. Ventricular repolarization components on the electrocardiogram: cellular basis and clinical significance. J Am Coll Cardiol. 2003 Aug 06; 42(3):401-9. PMID: 12906963.
      Citations:    
    307. Kowey PR, Kocovic DZ. Cardiology patient pages. Ambulatory electrocardiographic recording. Circulation. 2003 Aug 05; 108(5):e31-3. PMID: 12900497.
      Citations:    
    308. Kowey PR, Yan GX, Winkel E, Kao W. Pharmacologic and nonpharmacologic options to maintain sinus rhythm: guideline-based and new approaches. Am J Cardiol. 2003 Mar 20; 91(6A):33D-38D. PMID: 12670640.
      Citations:    
    309. Xu X, Yan GX, Wu Y, Liu T, Kowey PR. Electrophysiologic effects of SB-237376: a new antiarrhythmic compound with dual potassium and calcium channel blocking action. J Cardiovasc Pharmacol. 2003 Mar; 41(3):414-21. PMID: 12605020.
      Citations:    
    310. Medina-Ravell VA, Lankipalli RS, Yan GX, Antzelevitch C, Medina-Malpica NA, Medina-Malpica OA, Droogan C, Kowey PR. Effect of epicardial or biventricular pacing to prolong QT interval and increase transmural dispersion of repolarization: does resynchronization therapy pose a risk for patients predisposed to long QT or torsade de pointes? Circulation. 2003 Feb 11; 107(5):740-6. PMID: 12578878.
      Citations:    
    311. Sharma H, Sharma N, Burke JF, Yan GX, Kowey PR. Ischemia versus amiodarone induced polymorphic ventricular tachycardia. Pacing Clin Electrophysiol. 2002 Sep; 25(9):1382-4. PMID: 12380775.
      Citations:    
    312. Xu X, Salata JJ, Wang J, Wu Y, Yan GX, Liu T, Marinchak RA, Kowey PR. Increasing I(Ks) corrects abnormal repolarization in rabbit models of acquired LQT2 and ventricular hypertrophy. Am J Physiol Heart Circ Physiol. 2002 Aug; 283(2):H664-70. PMID: 12124214.
      Citations:    
    313. Kowey PR. The unnecessary pacemaker controversy revisited. Pacing Clin Electrophysiol. 2002 Mar; 25(3):269-71. PMID: 11990654.
      Citations:    
    Kowey's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (607)
    Explore
    _
    Co-Authors (12)
    Explore
    _
    Similar People (60)
    Explore
    _
    Same Department Expand Description
    Explore
    _